Dafna Gladman - Publications

Affiliations: 
Medical Science University of Toronto, Toronto, ON, Canada 
Area:
Immunology, Epidemiology

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Koppikar S, Colaco K, Harvey P, Akhtari S, Chandran V, Gladman DD, Cook R, Eder L. Incidence of and Risk Factors for Heart Failure in Patients with Psoriatic Disease - A Cohort Study. Arthritis Care & Research. PMID 33571391 DOI: 10.1002/acr.24578  1
2021 Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Annals of the Rheumatic Diseases. PMID 33568386 DOI: 10.1136/annrheumdis-2020-219373  0.64
2021 Whittall Garcia LP, Gladman DD, Urowitz M, Touma Z, Su J, Johnson SR. New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE. Annals of the Rheumatic Diseases. PMID 33452003 DOI: 10.1136/annrheumdis-2020-218670  0.64
2021 Mai L, Asaduzzaman A, Noamani B, Fortin PR, Gladman DD, Touma Z, Urowitz MB, Wither J. The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus. Arthritis Research & Therapy. 23: 29. PMID 33451338 DOI: 10.1186/s13075-021-02414-0  0.64
2020 De Marco G, Berekméri A, Coates LC, Dubash S, Emmel J, Gladman DD, Lubrano E, McGonagle DG, Mahmood F, Marchesoni A, Mason L, Ogdie A, Wittmann M, Helliwell PS, Marzo-Ortega H. Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative. Rheumatology Advances in Practice. 4: rkaa032. PMID 33542971 DOI: 10.1093/rap/rkaa032  0.32
2020 Polachek A, Muntyanu A, Lee KA, Ye JY, Chandran V, Cook RJ, Gladman DD. Malignancy in psoriatic disease: Results from prospective longitudinal cohorts. Seminars in Arthritis and Rheumatism. 51: 144-149. PMID 33383290 DOI: 10.1016/j.semarthrit.2020.12.008  1
2020 Kwok TSH, Sutton M, Yang Ye J, Pereira D, Chandran V, Gladman DD. Prevalence and factors associated with osteoporosis and bone mineral density testing in psoriatic arthritis. Arthritis Care & Research. PMID 33326187 DOI: 10.1002/acr.24538  1
2020 Rahmati S, O'Rielly DD, Li Q, Codner D, Dohey A, Jenkins K, Jurisica I, Gladman DD, Chandran V, Rahman P. Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis. Scientific Reports. 10: 21703. PMID 33303908 DOI: 10.1038/s41598-020-78866-2  1
2020 Tselios K, Gladman DD, Taheri C, Su J, Urowitz MB. Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis. The Journal of Rheumatology. PMID 33259331 DOI: 10.3899/jrheum.200161  0.44
2020 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, et al. Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis Care & Research. PMID 33152181 DOI: 10.1002/acr.24504  0.44
2020 Tselios K, Wakani L, Gladman DD, Su J, Urowitz MB. Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis. Rheumatology (Oxford, England). PMID 33140092 DOI: 10.1093/rheumatology/keaa655  0.44
2020 Colaco K, Widdifield J, Luo J, Rosen CF, Alhusayen R, Paterson JM, Campbell W, Tu K, Bernatsky S, Gladman DD, Eder L. Trends in Mortality and Cause-specific Mortality among patients with Psoriasis and Psoriatic Arthritis in Ontario, Canada. Journal of the American Academy of Dermatology. PMID 33096129 DOI: 10.1016/j.jaad.2020.10.031  1
2020 Coates LC, Merola JF, Mease PJ, Ogdie A, Gladman DD, Strand V, van Mens LJJ, Liu L, Yen PK, Collier DH, Kricorian G, Chung JB, Helliwell PS. Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. Rheumatology (Oxford, England). PMID 32864685 DOI: 10.1093/rheumatology/keaa271  0.32
2020 Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, et al. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Annals of the Rheumatic Diseases. PMID 32816709 DOI: 10.1136/annrheumdis-2020-217162  0.64
2020 Mease PJ, Gladman DD, Deodhar A, McGonagle DG, Nash P, Boehncke WH, Gottlieb A, Xu XL, Xu S, Hsia EC, Karyekar CS, Helliwell PS. Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study. Rmd Open. 6. PMID 32665433 DOI: 10.1136/rmdopen-2020-001217  0.56
2020 Almaghlouth I, Pullenayegum E, Gladman DD, Urowitz MB, Johnson SR. Propensity Score Methods in Rare Disease. A Demonstration Using Observational Data in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 32611674 DOI: 10.3899/jrheum.200254  0.44
2020 Urowitz MB, Gladman DD, Farewell V, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, et al. Accrual of atherosclerotic vascular events in a multicentre inception SLE cohort. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32515554 DOI: 10.1002/art.41392  0.44
2020 Goel N, Coates LC, De Marco G, Eder L, FitzGerald O, Helliwell PS, Leung YY, Maksymowych WP, Mease PJ, Østergaard M, O'Sullivan D, Poddubnyy D, Ritchlin CT, Gladman DD. GRAPPA 2019 Project Report. The Journal of Rheumatology. Supplement. 96: 53-57. PMID 32482770 DOI: 10.3899/jrheum.200129  1
2020 Leung YY, Tillett W, Orbai AM, Ogdie A, Eder L, Coates LC, Holland R, Antony A, Goel N, Mease PJ, Strand V, FitzGerald O, de Wit M, Lindsay CA, Callis Duffin K, ... Gladman DD, et al. The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. The Journal of Rheumatology. Supplement. 96: 46-49. PMID 32482768 DOI: 10.3899/jrheum.200127  1
2020 Tillett W, McHugh N, Orbai AM, Ogdie A, Leung YY, Coates LC, Mease PJ, Gladman DD, Brooke M, Packham J, O'Sullivan D, FitzGerald O, Helliwell PS. Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps. The Journal of Rheumatology. Supplement. 96: 11-18. PMID 32482762 DOI: 10.3899/jrheum.200121  0.32
2020 Elalouf O, Muntyanu A, Polachek A, Pereira D, Ye JY, Lee KA, Chandran V, Cook RJ, Gladman DD. Mortality in psoriatic arthritis: Risk, causes of death, predictors for death. Seminars in Arthritis and Rheumatism. 50: 571-575. PMID 32454305 DOI: 10.1016/j.semarthrit.2020.04.001  1
2020 Touma Z, Gladman DD, Zandy M, Su J, Anderson N, Urowitz MB. Identifying a response for the systemic lupus erythematosus disease activity glucocorticoid index (SLEDAI-2KG). Arthritis Care & Research. PMID 32433815 DOI: 10.1002/acr.24261  0.64
2020 Tselios K, Gladman DD, Su J, Urowitz MB. Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable? The Journal of Rheumatology. PMID 32238519 DOI: 10.3899/jrheum.191064  0.44
2020 Urowitz MB, Gladman DD, Ibañez D, Su J, Mursleen S, Sayani A, Alfonso J, Terres R, Iczkovitz S. Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort. The Journal of Rheumatology. PMID 32238510 DOI: 10.3899/jrheum.190259  0.44
2020 Helliwell PS, Gladman DD, Chakravarty SD, Kafka S, Karyekar CS, You Y, Campbell K, Sweet K, Kavanaugh A, Gensler LS. Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials. Rmd Open. 6. PMID 32209721 DOI: 10.1136/rmdopen-2019-001149  0.32
2020 Li Q, Chandran V, Tsoi L, O'Rielly D, Nair RP, Gladman D, Elder JT, Rahman P. Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV). Scientific Reports. 10: 4925. PMID 32188927 DOI: 10.1038/s41598-020-61981-5  1
2020 Alharbi S, Ye JY, Lee KA, Chandran V, Cook RJ, Gladman DD. Remission in psoriatic arthritis: Definition and predictors. Seminars in Arthritis and Rheumatism. PMID 32145969 DOI: 10.1016/j.semarthrit.2020.01.012  1
2020 Coates LC, Baraliakos X, Blanco FJ, Blanco-Morales E, Braun J, Chandran V, Luiz Fernandez-Sueiro J, FitzGerald O, Gallagher P, Gladman DD, Gubar E, Korotaeva T, Loginova E, Lubrano E, Mulero J, et al. The phenotype of axial spondyloarthritis: is it dependent on HLA-B27 status? Arthritis Care & Research. PMID 32100954 DOI: 10.1002/acr.24174  1
2020 Eder L, Widdifield J, Rosen CF, Alhusayen R, Cheng SY, Young J, Campbell W, Bernatsky S, Gladman DD, Paterson M, Tu K. Identifying and characterizing psoriasis and psoriatic arthritis patients in Ontario administrative data: a population-based study from 1991 to 2015. The Journal of Rheumatology. PMID 32062600 DOI: 10.3899/jrheum.190659  1
2020 Eder L, Tu K, Rosen CF, Alhusayen R, Cheng SY, Young J, Campbell W, Bernatsky S, Gladman DD, Paterson JM, Widdifield J. Health Care Utilization for Musculoskeletal Issues During the Pre-diagnosis Period in Psoriatic Arthritis - A Population-Based Study. Arthritis Care & Research. PMID 31961491 DOI: 10.1002/acr.24146  1
2020 Hanly JG, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, et al. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach. Annals of the Rheumatic Diseases. PMID 31915121 DOI: 10.1136/annrheumdis-2019-216150  0.44
2019 Hanneman K, Alberdi HV, Karur GR, Tselios K, Harvey PJ, Gladman DD, Akhtari S, Osuntokun T, Wald RM, Thavendiranathan P, Butany J, Urowitz MB. Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI. Jacc. Cardiovascular Imaging. PMID 31734202 DOI: 10.1016/j.jcmg.2019.09.014  0.64
2019 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, et al. Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis & Rheumatology (Hoboken, N.J.). PMID 31631584 DOI: 10.1002/art.41144  0.44
2019 Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, et al. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus. Journal of Autoimmunity. 102340. PMID 31629628 DOI: 10.1016/j.jaut.2019.102340  0.44
2019 Pakchotanon R, Ye Y, Cook RJ, Chandran V, Gladman DD. Liver Abnormalities in Patients with Psoriatic Arthritis. The Journal of Rheumatology. PMID 31615918 DOI: 10.3899/jrheum.181312  1
2019 Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, ... ... Gladman DD, et al. Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach. Arthritis Care & Research. PMID 31609532 DOI: 10.1002/acr.24092  0.44
2019 Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford, England). PMID 31593590 DOI: 10.1093/rheumatology/kez457  1
2019 Aydin SZ, Bakirci S, Kasapoglu E, Castillo-Gallego C, Alhussain FA, Ash ZR, Kurum E, McGonagle D, Marzo-Ortega H, Gladman D, Eder L. The relationship between physical examination and ultrasonography for large entheses is best for the Achilles tendon and patellar tendon origin. The Journal of Rheumatology. PMID 31474590 DOI: 10.3899/jrheum.190169  1
2019 Helliwell PS, Deodhar A, Gottlieb AB, Boehncke WH, Xu XL, Xu S, Wang Y, Hsia EC, Gladman DD, Ritchlin CT. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial. Arthritis Care & Research. PMID 31421033 DOI: 10.1002/acr.24046  0.56
2019 Colaco K, Ocampo V, Ayala AP, Harvey P, Gladman D, Piguet V, Eder L. Predictive utility of cardiovascular risk prediction algorithms in inflammatory rheumatic diseases: A systematic review. The Journal of Rheumatology. PMID 31416923 DOI: 10.3899/jrheum.190261  1
2019 Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, ... Gladman DD, et al. Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31390162 DOI: 10.1002/art.41070  0.44
2019 Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31385462 DOI: 10.1002/art.40930  0.64
2019 Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 31383717 DOI: 10.1136/annrheumdis-2018-214819  0.64
2019 Chandran V, Cook RJ, Gladman DD. Response to: 'Can biomarkers differentiate psoriatic arthritis from osteoarthritis?' by Tian . Annals of the Rheumatic Diseases. PMID 31272941 DOI: 10.1136/annrheumdis-2019-215762  1
2019 Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB. Dr. Tselios, , reply. The Journal of Rheumatology. PMID 31263072 DOI: 10.3899/jrheum.190255  0.64
2019 Webber D, Cao J, Dominguez D, Gladman DD, Levy DM, Ng L, Paterson AD, Touma Z, Urowitz MB, Wither JE, Silverman ED, Hiraki LT. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE. Rheumatology (Oxford, England). PMID 31236574 DOI: 10.1093/rheumatology/kez220  0.64
2019 Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V. Treating Psoriatic Arthritis to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects State Of Minimal Disease Activity (MDA). The Journal of Rheumatology. PMID 31203221 DOI: 10.3899/jrheum.181472  1
2019 Fei JZ, Perruccio AV, Ye JY, Gladman DD, Chandran V. The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis. Rheumatology (Oxford, England). PMID 31199486 DOI: 10.1093/rheumatology/kez202  1
2019 Sobchak C, Akhtari S, Harvey P, Gladman D, Chandran V, Cook R, Eder L. The value of carotid ultrasound in cardiovascular risk stratification in patients with psoriatic disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31165591 DOI: 10.1002/art.40925  1
2019 Goel N, FitzGerald O, Gladman DD, Helliwell PS, Kavanaugh A, Maksymowych WP, Mease PJ, Ritchlin CT, Coates LC. GRAPPA 2018 Project Report. The Journal of Rheumatology. Supplement. 95: 54-57. PMID 31154406 DOI: 10.3899/jrheum.190121  0.32
2019 Helliwell PS, Favier G, Gladman DD, Soriano ER, Kirkham BW, Coates LC, Puig L, Boehncke WH, Thaçi D. Best-practice Indicators in Psoriatic Disease Care. The Journal of Rheumatology. Supplement. 95: 38-45. PMID 31154403 DOI: 10.3899/jrheum.190120  0.56
2019 Leung YY, Orbai AM, Ogdie A, Coates LC, de Wit M, Callis Duffin K, Eder L, Gladman DD, Goel N, Mease PJ, Strand V, FitzGerald O, Tillett W. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. The Journal of Rheumatology. Supplement. 95: 33-37. PMID 31154402 DOI: 10.3899/jrheum.190122  1
2019 Jadon DR, Chandran V, Ogdie A, Pennington SR, Stober C, Gladman DD, de Wit M, O'Sullivan D, Mease P, Armstrong AW, Callis Duffin K, Magee C, Helliwell P, Ritchlin CT, FitzGerald O. Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology. Supplement. 95: 11-19. PMID 31154399 DOI: 10.3899/jrheum.190118  1
2019 Johnson K, Ye JY, Chandran V, Gladman DD. A novel role for the psoriatic arhtirtis impact of disease (PsAID) questionnaire. Seminars in Arthritis and Rheumatism. PMID 31101369 DOI: 10.1016/j.semarthrit.2019.04.001  1
2019 Patrick MT, Stuart PE, Raja K, Chi S, He Z, Voorhees JJ, Tejasvi T, Gudjonsson JE, Kahlenberg JM, Chandran V, Rahman P, Gladman DD, Nair RP, Elder JT, Tsoi LC. Integrative Approach to Reveal Cell Type Specificity and Gene Candidates for Psoriatic Arthritis Outside the MHC. Frontiers in Genetics. 10: 304. PMID 31031798 DOI: 10.3389/fgene.2019.00304  1
2019 Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Annals of the Rheumatic Diseases. PMID 30992296 DOI: 10.1136/annrheumdis-2018-214802  0.8
2019 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, et al. Construction of a frailty index as a novel health measure in systemic lupus erythematosus. The Journal of Rheumatology. PMID 30988130 DOI: 10.3899/jrheum.181338  0.44
2019 Chandran V, Abji F, Perruccio AV, Gandhi R, Li S, Cook RJ, Gladman DD. Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Annals of the Rheumatic Diseases. PMID 30910989 DOI: 10.1136/annrheumdis-2018-214737  1
2019 Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V. The development of a modified Psoriatic Arthritis Disease Activity Score (mPASDAS) using SF-12 as a measure of quality of life. Arthritis Care & Research. PMID 30875460 DOI: 10.1002/acr.23876  1
2019 Pollock RA, Zaman L, Chandran V, Gladman DD. Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis. Plos One. 14: e0212043. PMID 30779748 DOI: 10.1371/journal.pone.0212043  1
2019 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, et al. Evaluating the properties of a frailty index and its association with mortality risk among patients with systemic lupus erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30771242 DOI: 10.1002/art.40859  0.44
2019 Duarte-García A, Leung YY, Coates LC, Beaton D, Christensen R, Craig ET, de Wit M, Eder L, Fallon L, FitzGerald O, Gladman DD, Goel N, Holland R, Lindsay C, Maxwell L, et al. Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 Psoriatic Arthritis workshop report. The Journal of Rheumatology. PMID 30770518 DOI: 10.3899/jrheum.181089  1
2019 Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, ... ... Gladman DD, et al. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford, England). PMID 30753683 DOI: 10.1093/rheumatology/kez014  0.44
2019 Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, Kricorian G, Chung JB. Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30747501 DOI: 10.1002/art.40851  0.32
2019 Urowitz MB, Su J, Gladman DD. Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story. The Journal of Rheumatology. PMID 30709950 DOI: 10.3899/jrheum.180986  0.44
2019 Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, et al. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort. The Journal of Rheumatology. PMID 30647177 DOI: 10.3899/jrheum.180713  0.44
2019 Polachek A, Cook R, Chandran V, Gladman DD, Eder L. Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Research & Therapy. 21: 20. PMID 30642391 DOI: 10.1186/s13075-019-1814-1  1
2018 Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, ... ... Gladman DD, et al. Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort. Annals of the Rheumatic Diseases. PMID 30573656 DOI: 10.1136/annrheumdis-2018-214434  0.44
2018 Polachek A, Polachek Shlomi I, Spitzer K, Pereira D, Ye JY, Chandran V, Laskin CA, Gladman DD. Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls. Clinical Rheumatology. PMID 30535992 DOI: 10.1007/s10067-018-4385-7  1
2018 Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Disease course patterns in systemic lupus erythematosus. Lupus. 961203318817132. PMID 30526328 DOI: 10.1177/0961203318817132  0.64
2018 Feld J, Chandran V, Gladman DD. What Is Axial Psoriatic Arthritis? The Journal of Rheumatology. 45: 1611-1613. PMID 30504477 DOI: 10.3899/jrheum.180802  1
2018 Wakhlu A, Chandran V, Phumethum V, Shen H, Cook RJ, Gladman D. Comparison Between INSPIRE and Domjan method for measuring lumbar lateral flexion in patients of psoriatic arthritis (PsA) and correlation with radiographic damage. Clinical Rheumatology. PMID 30498874 DOI: 10.1007/s10067-018-4375-9  1
2018 Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Corrigendum to "Psoriatic arthritis disease activity during pregnancy and the first-year postpartum" [Semin. Arthritis Rheum. 46 (6) (2017) 740-745]. Seminars in Arthritis and Rheumatism. PMID 30477737 DOI: 10.1016/j.semarthrit.2018.11.001  1
2018 Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD. Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience. Clinical Rheumatology. PMID 30430267 DOI: 10.1007/s10067-018-4363-0  0.68
2018 Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Seminars in Arthritis and Rheumatism. PMID 30415943 DOI: 10.1016/j.semarthrit.2018.10.013  0.44
2018 Elmamoun M, Leung YY, O'Sullivan D, Steinkoenig I, Chandran V, Gladman DD, FitzGerald OM, Orbai AM, Eder L. Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set. The Journal of Rheumatology. PMID 30385708 DOI: 10.3899/jrheum.180195  1
2018 Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, ... Gladman DD, et al. Psychosis in Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30375754 DOI: 10.1002/art.40764  0.44
2018 Mease P, Coates LC, Helliwell PS, Stanislavchuk M, Rychlewska-Hanczewska A, Dudek A, Abi-Saab W, Tasset C, Meuleners L, Harrison P, Besuyen R, Van der Aa A, Mozaffarian N, Greer JM, Kunder R, ... ... Gladman DD, et al. Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. Lancet (London, England). PMID 30360969 DOI: 10.1016/S0140-6736(18)32483-8  0.32
2018 Tselios K, Deeb M, Gladman DD, Harvey P, Akhtari S, Mak S, Butany J, Urowitz MB. Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered? The Journal of Rheumatology. PMID 30323009 DOI: 10.3899/jrheum.180124  0.64
2018 Patrick MT, Stuart PE, Raja K, Gudjonsson JE, Tejasvi T, Yang J, Chandran V, Das S, Callis-Duffin K, Ellinghaus E, Enerbäck C, Esko T, Franke A, Kang HM, Krueger GG, ... ... Gladman DD, et al. Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients. Nature Communications. 9: 4178. PMID 30301895 DOI: 10.1038/s41467-018-06672-6  1
2018 Polachek A, Al-Johani R, Li S, Ye JY, Chandran V, Gladman D. Late onset psoriatic arthritis in a longitudinal cohort: Disease presentation, activity over time and prognosis. Seminars in Arthritis and Rheumatism. PMID 30243758 DOI: 10.1016/j.semarthrit.2018.08.005  1
2018 Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, et al. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 30173152 DOI: 10.3899/jrheum.171459  0.64
2018 Eder L, Widdifield J, Rosen CF, Cook R, Lee KA, Alhusayen R, Paterson JM, Cheng SY, Jabbari S, Campbell W, Bernatsky S, Gladman DD, Tu K. Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: A population-based study. Arthritis Care & Research. PMID 30171803 DOI: 10.1002/acr.23743  1
2018 Yap KS, Ye JY, Li S, Gladman DD, Chandran V. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 30077991 DOI: 10.1136/annrheumdis-2018-213334  1
2018 Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB. Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials? The Journal of Rheumatology. PMID 30068764 DOI: 10.3899/jrheum.171436  0.64
2018 Keeling SO, Bissonauth A, Bernatsky S, Vandermeer B, Fortin PR, Gladman DD, Peschken C, Urowitz MB. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada. The Journal of Rheumatology. PMID 30068762 DOI: 10.3899/jrheum.171307  0.44
2018 Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Clinical remission and low disease activity have comparable outcomes over 10 years in systemic lupus erythematosus. Arthritis Care & Research. PMID 30055090 DOI: 10.1002/acr.23720  0.64
2018 Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, ... ... Gladman DD, et al. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care & Research. PMID 30044551 DOI: 10.1002/acr.23712  0.44
2018 Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Scarpa R, Marchesoni A, Taylor WJ, Salvarani C, Kalden J, Lubrano E, Carneiro S, Piga M, et al. Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study. The Journal of Rheumatology. PMID 29907666 DOI: 10.3899/jrheum.171183  0.32
2018 Jadon DR, Chandran V, Stober C, Ogdie A, Armstrong AW, Callis Duffin K, Gladman DD, Helliwell PS, O'Sullivan D, de Wit M, FitzGerald O, Ritchlin CT. Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology. Supplement. 94: 54-61. PMID 29858357 DOI: 10.3899/jrheum.180141  1
2018 Holland R, Tillett W, Ogdie A, Leung YY, Gladman DD, Callis Duffin K, Coates LC, Mease PJ, Eder L, Strand V, Elmamoun M, Højgaard P, Chau J, de Wit M, Goel N, et al. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting. The Journal of Rheumatology. Supplement. 94: 17-25. PMID 29858348 DOI: 10.3899/jrheum.180142  1
2018 Helliwell PS, Gladman DD, Gottlieb AB. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. Supplement. 94: 1-3. PMID 29858345 DOI: 10.3899/jrheum.180129  0.32
2018 Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Monophasic Disease Course in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29858240 DOI: 10.3899/jrheum.171319  0.64
2018 Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nature Reviews. Rheumatology. PMID 29752461 DOI: 10.1038/s41584-018-0006-8  1
2018 Chandran V, Stecher L, Farewell V, Gladman DD. Patterns of peripheral joint involvement in psoriatic arthritis-Symmetric, ray and/or row? Seminars in Arthritis and Rheumatism. PMID 29724452 DOI: 10.1016/j.semarthrit.2018.03.002  1
2018 Touma Z, Gladman DD, Su J, Anderson N, Urowitz MB. A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index. Rheumatology (Oxford, England). PMID 29688532 DOI: 10.1093/rheumatology/key103  0.64
2018 Tselios K, Gladman DD, Harvey P, Su J, Urowitz MB. Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors. Lupus. 961203318770526. PMID 29665757 DOI: 10.1177/0961203318770526  0.64
2018 Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB. Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus. 961203318770018. PMID 29642752 DOI: 10.1177/0961203318770018  0.44
2018 Eder L, Harvey P, Chandran V, Rosen CF, Dutz J, Elder JT, Rahman P, Ritchlin CT, Rohekar S, Hayday R, Barac S, Feld J, Zisman D, Gladman DD. Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study. The Journal of Rheumatology. PMID 29419462 DOI: 10.3899/jrheum.170379  1
2018 Polachek A, Cook R, Chandran V, Abji F, Gladman D, Eder L. The Association between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29361203 DOI: 10.1002/art.40423  1
2018 Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, ... ... Gladman DD, et al. Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort. Rheumatology (Oxford, England). PMID 29361147 DOI: 10.1093/rheumatology/kex444  0.44
2018 Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PR, Yelin EH, Ginzler E, Hanly JG, Peschken C, Gordon C, Nived O, Aranow C, Bae SC, Isenberg D, et al. Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29335347 DOI: 10.3899/jrheum.170652  0.44
2018 Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, ... Gladman DD, et al. Cerebrovascular Events in Systemic Lupus Erythematosus. Arthritis Care & Research. PMID 29316357 DOI: 10.1002/acr.23509  0.44
2017 Touma Z, Gladman DD. Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments. Lupus Science & Medicine. 4: e000239. PMID 29344386 DOI: 10.1136/lupus-2017-000239  0.64
2017 Ferreira I, Croca S, Raimondo MG, Matharu M, Miller S, Giles I, Isenberg D, Ioannou Y, Hanly JG, Urowitz MB, Anderson N, Aranow C, Askanase A, Bae SC, Bernatsky S, ... ... Gladman D, et al. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study. Arthritis Research & Therapy. 19: 287. PMID 29273092 DOI: 10.1186/s13075-017-1495-6  0.44
2017 AlJohani R, Polachek A, Ye JY, Chandran V, Gladman DD. Characteristic and Outcome of Psoriatic Arthritis Patients with Hyperuricemia. The Journal of Rheumatology. PMID 29196385 DOI: 10.3899/jrheum.170384  1
2017 Barber MRW, Hanly JG, Su L, Urowitz MB, Pierre YS, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, ... ... Gladman DD, et al. Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach. Arthritis Care & Research. PMID 29193883 DOI: 10.1002/acr.23480  0.44
2017 Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, et al. GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29193765 DOI: 10.1002/art.40391  0.8
2017 Patel P, Rosen CF, Chandran V, Ye YJ, Gladman DD. Addressing comorbidities in psoriatic disease. Rheumatology International. PMID 29185085 DOI: 10.1007/s00296-017-3895-y  1
2017 Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis. Clinical and Experimental Rheumatology. PMID 29148410  1
2017 Pakchotanon R, Gladman DD, Su J, Urowitz MB. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29142038 DOI: 10.3899/jrheum.170645  0.44
2017 Tselios K, Gladman DD, Su J, Ace O, Urowitz MB. Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study. The Journal of Rheumatology. PMID 29093154 DOI: 10.3899/jrheum.161121  0.44
2017 Eder L, Joshi AA, Dey AK, Cook R, Siegel EL, Gladman DD, Mehta NN. TNF-α inhibitors are associated with reduced indices of subclinical atherosclerosis in patients with psoriatic disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29088580 DOI: 10.1002/art.40366  1
2017 Tselios K, Lam WC, Urowitz MB, Gladman DD. Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. PMID 29059086 DOI: 10.1097/RHU.0000000000000600  0.44
2017 Højgaard P, Klokker L, Orbai AM, Holmsted K, Bartels EM, Leung YY, Goel N, de Wit M, Gladman DD, Mease P, Dreyer L, Kristensen LE, FitzGerald O, Tillett W, Gossec L, et al. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism. PMID 29037523 DOI: 10.1016/j.semarthrit.2017.09.002  0.36
2017 Dand N, Mucha S, Tsoi LC, Mahil SK, Stuart PE, Arnold A, Baurecht H, Burden AD, Duffin KC, Chandran V, Curtis CJ, Das S, Ellinghaus D, Ellinghaus E, Enerback C, ... ... Gladman DD, et al. Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling. Human Molecular Genetics. PMID 28973304 DOI: 10.1093/hmg/ddx328  1
2017 Pakchotanon R, Gladman DD, Su J, Urowitz MB. Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis. Lupus. 961203317726376. PMID 28857717 DOI: 10.1177/0961203317726376  0.44
2017 Polachek A, Cook R, Chandran V, Gladman DD, Eder L. The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Research & Therapy. 19: 189. PMID 28810926 DOI: 10.1186/s13075-017-1399-5  1
2017 Berinstein J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, Gladman DD. Association of variably expressed KIR3dl1 alleles with psoriatic disease. Clinical Rheumatology. PMID 28801811 DOI: 10.1007/s10067-017-3784-5  1
2017 Deeb M, Tselios K, Gladman DD, Su J, Urowitz MB. Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience. Lupus. 961203317722411. PMID 28758573 DOI: 10.1177/0961203317722411  0.44
2017 Langefeld CD, Ainsworth HC, Graham DSC, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, ... ... Gladman DD, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nature Communications. 8: 16021. PMID 28714469 DOI: 10.1038/ncomms16021  0.52
2017 Maldonado-Ficco H, Sheane BJ, Thavaneswaran A, Chandran V, Gladman DD. Magnetic Resonance Imaging in Psoriatic Arthritis: A Descriptive Study of Indications, Features and Effect on Treatment Change. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. PMID 28700527 DOI: 10.1097/RHU.0000000000000558  1
2017 Urowitz MB, Gladman DD. Reply. Arthritis Care & Research. PMID 28686813 DOI: 10.1002/acr.23309  0.44
2017 Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewé R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases. PMID 28684559 DOI: 10.1136/annrheumdis-2017-211734  0.36
2017 Wong ITY, Chandran V, Li S, Gladman DD. Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors. The Journal of Rheumatology. PMID 28620064 DOI: 10.3899/jrheum.161330  1
2017 Gu K, Gladman DD, Su J, Urowitz MB. Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center. The Journal of Rheumatology. PMID 28620060 DOI: 10.3899/jrheum.170072  0.44
2017 Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong CH, Karsh J, Khraishi MM, et al. Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice. The Journal of Rheumatology. 44: 519-534. PMID 28604347 DOI: 10.3899/jrheum.161473  1
2017 Chan K, Clarke AE, Ramsey-Goldman R, Foulkes W, Tessier Cloutier B, Urowitz MB, Gladman D, Nived O, Romero-Diaz J, Petri M, Ginzler E, Fortin PR, Bae SC, Wallace DJ, Yelin EH, et al. Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment. Lupus. 961203317713146. PMID 28595511 DOI: 10.1177/0961203317713146  0.44
2017 Aljohani R, Gladman DD, Su J, Urowitz MB. Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics. Clinical Rheumatology. PMID 28589322 DOI: 10.1007/s10067-017-3713-7  0.44
2017 Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, Ellinghaus E, Barker JN, Chandran V, Dand N, Duffin KC, Enerbäck C, Esko T, Franke A, Gladman DD, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nature Communications. 8: 15382. PMID 28537254 DOI: 10.1038/ncomms15382  1
2017 Gladman DD, Dhillon N, Su J, Urowitz MB. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus. 961203317711012. PMID 28530464 DOI: 10.1177/0961203317711012  0.44
2017 Ogdie A, de Wit M, Callis Duffin K, Campbell W, Chau J, Coates LC, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, James J, Kalyoncu U, Latella J, Lindsay C, et al. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. 44: 697-700. PMID 28461531 DOI: 10.3899/jrheum.170150  1
2017 Favier G, Gladman DD, Merola JF, Armstrong AW, Boehncke WH, Helliwell PS. Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting. The Journal of Rheumatology. 44: 674-678. PMID 28461523 DOI: 10.3899/jrheum.170142  0.56
2017 Jadon DR, Gladman DD, Mease PJ, FitzGerald O, Chandran V, Goel N, Rosen CF, Maksymowych WP, Ritchlin CT, Ogdie A, Coates LC, Cauli A, Soriano ER, Husni ME, Campbell W, et al. Proceedings of the GRAPPA 2016 Retreat. The Journal of Rheumatology. 44: 668-673. PMID 28461522 DOI: 10.3899/jrheum.170141  1
2017 Helliwell PS, Gladman DD, Gottlieb AB. Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. 44: 658-660. PMID 28461520 DOI: 10.3899/jrheum.170139  0.32
2017 Aljohani R, Gladman DD, Su J, Urowitz MB. Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus. 961203317696593. PMID 28420066 DOI: 10.1177/0961203317696593  0.44
2017 Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, ... ... Gladman DD, et al. The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients. Lupus. 961203317692437. PMID 28420054 DOI: 10.1177/0961203317692437  0.44
2017 Eder L, Abji F, Rosen CF, Chandran V, Gladman DD. The Association Between Obesity and Clinical Features of Psoriatic Arthritis: A Case-control Study. The Journal of Rheumatology. PMID 28202737 DOI: 10.3899/jrheum.160532  1
2017 Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Seminars in Arthritis and Rheumatism. PMID 28196621 DOI: 10.1016/j.semarthrit.2017.01.002  1
2017 Al Rayes H, Harvey PJ, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease. Arthritis Research & Therapy. 19: 31. PMID 28183339 DOI: 10.1186/s13075-017-1240-1  0.64
2017 Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD. Psoriasis in systemic lupus erythematosus: a single-center experience. Clinical Rheumatology. PMID 28168661 DOI: 10.1007/s10067-017-3566-0  0.68
2017 Zisman D, Gladman DD, Stoll ML, Strand V, Lavi I, Hsu JJ, Mellins ED. The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes. The Journal of Rheumatology. PMID 28148698 DOI: 10.3899/jrheum.160717  0.4
2017 Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, Campbell W, FitzGerald O, Gladman DD, Goel N, Gossec L, Hoejgaard P, Leung YY, Lindsay C, Strand V, et al. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016. The Journal of Rheumatology. PMID 28148697 DOI: 10.3899/jrheum.160904  1
2017 Eder L, Chandran V, Cook R, Gladman DD. The Risk of Developing Diabetes Mellitus in Patients with Psoriatic Arthritis: A Cohort Study. The Journal of Rheumatology. PMID 28148695 DOI: 10.3899/jrheum.160861  1
2017 Ibrahim A, Gladman DD, Thavaneswaran A, Eder L, Helliwell P, Cook RJ, Chandran V. Radiographic scoring instruments have moderate sensitivity but high specificity for detecting change in axial psoriatic arthritis. Arthritis Care & Research. PMID 28085226 DOI: 10.1002/acr.23189  1
2017 Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatology : Research and Reviews. 9: 1-9. PMID 28053559 DOI: 10.2147/OARRR.S123549  0.44
2016 Polachek A, Li S, Chandran V, Gladman D. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: Incidence, prevalence, characteristics and outcome. Arthritis Care & Research. PMID 27998023 DOI: 10.1002/acr.23174  1
2016 Pollock RA, Abji F, Gladman DD. Epigenetics of psoriatic disease: A systematic review and critical appraisal. Journal of Autoimmunity. PMID 27965059 DOI: 10.1016/j.jaut.2016.12.002  0.72
2016 Muntyanu A, Abji F, Liang K, Pollock RA, Chandran V, Gladman DD. Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis. Arthritis Research & Therapy. 18: 296. PMID 27964744 DOI: 10.1186/s13075-016-1196-6  1
2016 Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Psoriasis. Nature Reviews. Disease Primers. 2: 16082. PMID 27883001 DOI: 10.1038/nrdp.2016.82  0.32
2016 Eder L, Polachek A, Rosen CF, Chandran V, Cook R, Gladman DD. The development of PsA in patients with psoriasis is preceded by a period of non-specific musculoskeletal symptoms: A prospective cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27792862 DOI: 10.1002/art.39973  1
2016 Yap KS, Urowitz MB, Mahood Q, Medina-Rosas J, Sabapathy A, Lawson D, Su J, Gladman DD, Touma Z. The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: Systematic literature review and analysis of the Toronto lupus cohort. Seminars in Arthritis and Rheumatism. PMID 27769590 DOI: 10.1016/j.semarthrit.2016.09.008  0.64
2016 Polachek A, Gladman DD, Su J, Urowitz MB. Defining low disease activity in systemic lupus erythematosus. Arthritis Care & Research. PMID 27696791 DOI: 10.1002/acr.23109  0.68
2016 Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PF, Ginzler E, Romero-Diaz J, Peschken C, Jacobsen S, Hanly JG, Gordon C, Nived O, Yelin EH, Isenberg D, et al. Breast cancer in systemic lupus. Lupus. PMID 27687028 DOI: 10.1177/0961203316664595  0.44
2016 Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, Tillett W, Elmamoun M, Callis Duffin K, Campbell W, Christensen R, Coates L, Dures E, Eder L, FitzGerald O, ... Gladman D, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Annals of the Rheumatic Diseases. PMID 27613807 DOI: 10.1136/annrheumdis-2016-210242  1
2016 Tselios K, Gladman DD, Su J, Urowitz MB. Dr. Tselios, et al reply. The Journal of Rheumatology. 43: 1767. PMID 27587017 DOI: 10.3899/jrheum.160749  1
2016 Eder L, Abji F, Rosen CF, Chandran V, Cook RJ, Gladman DD. The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease. The Journal of Rheumatology. PMID 27585683 DOI: 10.3899/jrheum.151469  1
2016 Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Annals of the Rheumatic Diseases. PMID 27553214 DOI: 10.1136/annrheumdis-2016-209709  1
2016 Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB. Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 22: 287-8. PMID 27464781 DOI: 10.1097/RHU.0000000000000400  0.64
2016 Sheane BJ, Thavaneswaran A, Gladman DD, Chandran V. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis. The Journal of Rheumatology. PMID 27422895 DOI: 10.3899/jrheum.160111  1
2016 Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. C-X-C Motif Chemokine 10 is a Possible Biomarker for the Development of Psoriatic Arthritis among Patients with Psoriasis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27389865 DOI: 10.1002/art.39800  1
2016 Chandran S, Aldei A, Johnson SR, Cheung AM, Salonen D, Gladman DD. Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review. Seminars in Arthritis and Rheumatism. PMID 27346576 DOI: 10.1016/j.semarthrit.2016.05.005  0.8
2016 Sheane BJ, Gladman DD, Su J, Urowitz MB. Disease outcomes in corticosteroid-naïve patients with systemic lupus erythematosus. Arthritis Care & Research. PMID 27214378 DOI: 10.1002/acr.22938  0.8
2016 Gladman DD, Mease PJ, Boehncke WH, Helliwell PS, Callis Duffin K. Presidential Round Table: A Report from the GRAPPA Annual Meeting. The Journal of Rheumatology. 43: 986-9. PMID 27134275 DOI: 10.3899/jrheum.160120  0.56
2016 Mease PJ, Helliwell PS, Boehncke WH, Coates LC, FitzGerald O, Gladman DD, Deodhar AA, Callis Duffin K. GRAPPA 2015 Research and Education Project Reports. The Journal of Rheumatology. 43: 979-85. PMID 27134274 DOI: 10.3899/jrheum.160119  0.56
2016 de Wit M, Campbell W, Coates LC, Gladman DD, James J, Lindsay CA, MacDonald R, Moverley AR, Ogdie A, Orbai AM, O'Sullivan D, Parkinson A, Steinkoenig I, Tillett W, Goel N. Let's Talk about Inclusion: A Report on Patient Research Partner Involvement in the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology. 43: 970-3. PMID 27134272 DOI: 10.3899/jrheum.160117  1
2016 Orbai AM, Mease PJ, de Wit M, Kalyoncu U, Campbell W, Tillett W, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, Gossec L, Lindsay CA, Steinkoenig I, Helliwell PS, et al. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology. 43: 965-9. PMID 27134271 DOI: 10.3899/jrheum.160116  1
2016 Boehncke WH, Gladman DD, Helliwell PS. Prologue: 2015 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. 43: 949-51. PMID 27134267 DOI: 10.3899/jrheum.160112  0.56
2016 Touma Z, Thavaneswaran A, Chandran V, Pellett F, Cook RJ, Gladman DD. Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study. The Journal of Rheumatology. PMID 27036389 DOI: 10.3899/jrheum.150466  1
2016 Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, ... ... Gladman DD, et al. A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26991067 DOI: 10.1002/art.39674  1
2016 Kalyoncu U, Ogdie A, Campbell W, Bingham CO, de Wit M, Gladman DD, Mease P, Steinkoenig I, Strand V, Riese VG, Orbai AM. Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. Rmd Open. 2: e000217. PMID 26966554 DOI: 10.1136/rmdopen-2015-000217  1
2016 Urowitz MB, Ibañez D, Su J, Gladman DD. Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 26879352 DOI: 10.3899/jrheum.150983  1
2016 Tselios K, Gladman DD, Su J, Urowitz MB. Does renin-angiotensin system blockade protect lupus nephritis patients from atherosclerotic cardiovascular events? A case-control study. Arthritis Care & Research. PMID 26866934 DOI: 10.1002/acr.22857  1
2016 Tselios K, Gladman DD, Su J, Urowitz MB. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. The Journal of Rheumatology. PMID 26773121 DOI: 10.3899/jrheum.150779  0.44
2016 Haddad A, Li S, Thavaneswaran A, Cook RJ, Chandran V, Gladman DD. The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts. The Journal of Rheumatology. PMID 26773102 DOI: 10.3899/jrheum.140067  1
2016 Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26749174 DOI: 10.1002/art.39573  1
2016 Tselios K, Sheane BJ, Gladman DD, Urowitz MB. Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review. The Journal of Rheumatology. 43: 54-65. PMID 26568591 DOI: 10.3899/jrheum.150460  0.8
2016 Mahieu M, Gladman D, Ramsey-Goldman R. Disease Development and Outcomes Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. 31-37. DOI: 10.1016/B978-0-12-801917-7.00005-X  1
2016 Gladman DD. Historical perspectives on psoriatic arthritis Psoriatic Arthritis and Psoriasis: Pathology and Clinical Aspects. 3-6. DOI: 10.1007/978-3-319-19530-8_1  1
2015 Tselios K, Koumaras C, Gladman DD, Urowitz MB. Dyslipidemia in systemic lupus erythematosus: just another comorbidity? Seminars in Arthritis and Rheumatism. PMID 26711309 DOI: 10.1016/j.semarthrit.2015.10.010  1
2015 Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R, Li Y, Wen X, Enerbäck C, Gudjonsson JE, Kõks S, ... ... Gladman DD, et al. Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. American Journal of Human Genetics. PMID 26626624 DOI: 10.1016/j.ajhg.2015.10.019  1
2015 Tselios K, Gladman DD, Su J, Urowitz MB. Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus. Lupus. PMID 26585070 DOI: 10.1177/0961203315617845  0.44
2015 Steiman AJ, Gladman DD, Ibañez D, Noamani B, Landolt-Marticorena C, Urowitz MB, Wither JE. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. The Journal of Rheumatology. 42: 2318-26. PMID 26568589 DOI: 10.3899/jrheum.150040  1
2015 Eder L, Haddad A, Rosen CF, Lee KA, Chandran V, Cook R, Gladman DD. The incidence and risk factors for psoriatic arthritis in patients with psoriasis - a prospective cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26555117 DOI: 10.1002/art.39494  1
2015 Gladman DD. Toward Treating to Target in Psoriatic Arthritis. The Journal of Rheumatology. Supplement. 93: 14-6. PMID 26523047 DOI: 10.3899/jrheum.150626  1
2015 Medina-Rosas J, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus. Arthritis Research & Therapy. 17: 296. PMID 26497948 DOI: 10.1186/s13075-015-0808-x  1
2015 Eder L, Wu Y, Chandran V, Cook R, Gladman DD. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 26493817 DOI: 10.1136/annrheumdis-2015-207980  1
2015 Gladman DD. Clinical Features and Diagnostic Considerations in Psoriatic Arthritis. Rheumatic Diseases Clinics of North America. 41: 569-79. PMID 26476219 DOI: 10.1016/j.rdc.2015.07.003  1
2015 Gladman DD. Is it time for treat to target in psoriatic arthritis? Lancet (London, England). 386: 2450-2. PMID 26433319 DOI: 10.1016/S0140-6736(15)00348-7  1
2015 Eder L, Gladman DD. Atherosclerosis in psoriatic disease: latest evidence and clinical implications. Therapeutic Advances in Musculoskeletal Disease. 7: 187-95. PMID 26425147 DOI: 10.1177/1759720X15591801  1
2015 Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, ... Gladman DD, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford, England). PMID 26342222 DOI: 10.1093/rheumatology/kev311  0.44
2015 Jackson CH, Su L, Gladman DD, Farewell VT. On modelling minimal disease activity. Arthritis Care & Research. PMID 26315478 DOI: 10.1002/acr.22687  1
2015 Lenz TL, Deutsch AJ, Han B, Hu X, Okada Y, Eyre S, Knapp M, Zhernakova A, Huizinga TW, Abecasis G, Becker J, Boeckxstaens GE, Chen WM, Franke A, Gladman DD, et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nature Genetics. PMID 26258845 DOI: 10.1038/ng.3379  1
2015 Gladman DD. Reply: To PMID 25545846. Arthritis & Rheumatology (Hoboken, N.J.). 67: 3096. PMID 26245189 DOI: 10.1002/art.39305  1
2015 Touma Z, Gladman DD, Su J, Ibañez D, Urowitz MB. SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement. The Journal of Rheumatology. 42: 1401-5. PMID 26077403 DOI: 10.3899/jrheum.141088  1
2015 Pollock RA, Thavaneswaran A, Pellett F, Chandran V, Petronis A, Rahman P, Gladman DD. Further Evidence Supporting a Parent-of-Origin Effect in Psoriatic Disease. Arthritis Care & Research. 67: 1586-90. PMID 26017758 DOI: 10.1002/acr.22625  1
2015 Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, Ward M, Gensler LS, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, ... ... Gladman DD, et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nature Communications. 6: 7146. PMID 25994336 DOI: 10.1038/ncomms8146  1
2015 Kaka H, Ayearst R, Tran M, Touma Z, Bagovich M, Vinik O, Somaily M, Haddad A, Gladman DD, Chandran V. DEVELOPING AN IPAD® APPLICATION FOR DATA COLLECTION IN A RHEUMATOLOGY RESEARCH CLINIC. International Journal of Technology Assessment in Health Care. 31: 99-102. PMID 25991410 DOI: 10.1017/S0266462315000069  1
2015 Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knight J, Tejasvi T, Kang HM, Allen MH, Lambert S, Stoll SW, Weidinger S, Gudjonsson JE, Koks S, Kingo K, ... ... Gladman DD, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nature Communications. 6: 7001. PMID 25939698 DOI: 10.1038/ncomms8001  1
2015 Tillett W, Eder L, Goel N, De Wit M, Gladman DD, FitzGerald O, Campbell W, Helliwell PS, Gossec L, Orbai AM, Ogdie A, Strand V, McHugh NJ, Mease PJ. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014. The Journal of Rheumatology. PMID 25934828 DOI: 10.3899/jrheum.141156  1
2015 Robinson PC, Costello ME, Leo P, Bradbury LA, Hollis K, Cortes A, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, ... ... Gladman DD, et al. ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients. Annals of the Rheumatic Diseases. 74: 1627-9. PMID 25917849 DOI: 10.1136/annrheumdis-2015-207416  1
2015 Tom BD, Chandran V, Farewell VT, Rosen CF, Gladman DD. Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2). The Journal of Rheumatology. 42: 841-6. PMID 25834198 DOI: 10.3899/jrheum.140857  1
2015 Kavanaugh A, van der Heijde D, Beutler A, Gladman D, Mease P, Krueger GG, McInnes IB, Helliwell P, Coates LC, Xu S. Patients with psoriatic arthritis who achieve minimal disease activity in response to golimumab therapy demonstrate less radiographic progression: Results through 5 years of the randomized, placebo-controlled, GO-REVEAL study. Arthritis Care & Research. PMID 25779603 DOI: 10.1002/acr.22576  0.36
2015 Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, ... ... Gladman DD, et al. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1837-47. PMID 25778456 DOI: 10.1002/art.39111  1
2015 Steiman AJ, Urowitz MB, Ibañez D, Li TT, Gladman DD, Wither J. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. The Journal of Rheumatology. 42: 810-6. PMID 25729033 DOI: 10.3899/jrheum.140796  1
2015 Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada. The Journal of Rheumatology. 42: 654-64. PMID 25684770 DOI: 10.3899/jrheum.141000  1
2015 Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations. The Journal of Rheumatology. 42: 665-81. PMID 25684768 DOI: 10.3899/jrheum.141001  1
2015 Chang NH, Li TT, Kim JJ, Landolt-Marticorena C, Fortin PR, Gladman DD, Urowitz MB, Wither JE. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus. Journal of Autoimmunity. 58: 100-10. PMID 25678471 DOI: 10.1016/j.jaut.2015.01.009  1
2015 Ding JY, Ibañez D, Gladman DD, Urowitz MB. Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity. The Journal of Rheumatology. 42: 437-40. PMID 25593226 DOI: 10.3899/jrheum.140415  1
2015 Gladman DD. Editorial: What is peripheral spondyloarthritis? Arthritis & Rheumatology (Hoboken, N.J.). 67: 865-8. PMID 25545846 DOI: 10.1002/art.39014  1
2015 Haddad A, Thavaneswaran A, Ruiz-Arruza I, Pellett F, Chandran V, Cook RJ, Gladman DD. Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritis. Arthritis Care & Research. 67: 842-7. PMID 25469741 DOI: 10.1002/acr.22529  1
2015 Eder L, Chandran V, Gladman DD. What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? Current Opinion in Rheumatology. 27: 91-8. PMID 25415529 DOI: 10.1097/BOR.0000000000000136  1
2015 Pollock RA, Abji F, Liang K, Chandran V, Pellett FJ, Virtanen C, Gladman DD. Gene expression differences between psoriasis patients with and without inflammatory arthritis. The Journal of Investigative Dermatology. 135: 620-3. PMID 25243786 DOI: 10.1038/jid.2014.414  1
2015 Li T, Prokopec SD, Morrison S, Lou W, Reich H, Gladman D, Urowitz M, Scholey J, Fortin PR, Boutros PC, Wither J, Landolt-Marticorena C. Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus. Rheumatology (Oxford, England). 54: 449-57. PMID 25193804 DOI: 10.1093/rheumatology/keu326  1
2015 Das S, Stuart PE, Ding J, Tejasvi T, Li Y, Tsoi LC, Chandran V, Fischer J, Helms C, Duffin KC, Voorhees JJ, Bowcock AM, Krueger GG, Lathrop GM, Nair RP, ... ... Gladman D, et al. Fine mapping of eight psoriasis susceptibility loci. European Journal of Human Genetics : Ejhg. 23: 844-53. PMID 25182136 DOI: 10.1038/ejhg.2014.172  1
2015 Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg DA, Wallace DJ, Ramsey-Goldman R, Bae SC, Hanly JG, ... ... Gladman DD, et al. Anti-C1q antibodies in systemic lupus erythematosus. Lupus. 24: 42-9. PMID 25124676 DOI: 10.1177/0961203314547791  1
2015 Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care & Research. 67: 264-72. PMID 25047020 DOI: 10.1002/acr.22401  1
2015 Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T, Joseph L, Belisle P, Bae SC, Hanly JG, Wallace DJ, Gordon C, Isenberg D, Rahman A, Gladman DD, et al. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care & Research. 67: 128-35. PMID 24838943 DOI: 10.1002/acr.22370  1
2015 Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, et al. Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases. 74: 1530-6. PMID 24692585 DOI: 10.1136/annrheumdis-2013-203933  1
2015 Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 74: 813-7. PMID 24431392 DOI: 10.1136/annrheumdis-2013-204448  1
2015 Tillett W, Eder L, Goel N, De Wit M, Ogdie A, Orbai AM, Campbell W, Fitzgerald O, McHugh NJ, Gladman DD, Strand V, Mease PJ. Review of the psoriatic arthritis working group at OMERACT 12: A report from the GRAPPA 2014 annual meeting Journal of Rheumatology. 42: 1048-1051. DOI: 10.3899/jrheum.150131  1
2015 De Wit M, Campbell W, Orbai AM, Tillett W, Fitzgerald O, Gladman DD, Lindsay CA, McHugh NJ, Mease PJ, O'Sullivan D, Steinkoenig I, Windisch G, Goel N. Building bridges between researchers and patient research partners: A report from the grappa 2014 annual meeting Journal of Rheumatology. 42: 1021-1026. DOI: 10.3899/jrheum.150123  1
2015 Boehncke WH, Gladman DD. Prologue: 2014 annual meeting of the group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA) Journal of Rheumatology. 42: 1011-1013. DOI: 10.3899/jrheum.150120  1
2015 Haddad A, Gladman DD, Ibañez D, Urowitz MB. Vascular- and pregnancy-related outcomes in patients with systemic lupus erythematosus with positive antiphospholipid profile and thrombocytopenia Lupus. 24: 822-826. DOI: 10.1177/0961203314565689  1
2014 Furie R, Petri MA, Strand V, Gladman DD, Zhong ZJ, Freimuth WW. Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials. Lupus Science & Medicine. 1: e000031. PMID 25396065 DOI: 10.1136/lupus-2014-000031  1
2014 Nash P, Lubrano E, Cauli A, Taylor WJ, Olivieri I, Gladman DD. Updated guidelines for the management of axial disease in psoriatic arthritis. The Journal of Rheumatology. 41: 2286-9. PMID 25362712 DOI: 10.3899/jrheum.140877  1
2014 Haddad A, Thavaneswaran A, Abji F, Pellett F, Chandran V, Wither JE, Gladman DD. Immunoglobulin G subclass analysis in psoriatic arthritis. The Journal of Rheumatology. 41: 2421-4. PMID 25320220 DOI: 10.3899/jrheum.131477  1
2014 Asiri A, Thavaneswaran A, Kalman-Lamb G, Chandran V, Gladman DD. The effectiveness of leflunomide in psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 728-31. PMID 25151858  1
2014 Okada Y, Han B, Tsoi LC, Stuart PE, Ellinghaus E, Tejasvi T, Chandran V, Pellett F, Pollock R, Bowcock AM, Krueger GG, Weichenthal M, Voorhees JJ, Rahman P, Gregersen PK, ... ... Gladman DD, et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. American Journal of Human Genetics. 95: 162-72. PMID 25087609 DOI: 10.1016/j.ajhg.2014.07.002  1
2014 Steiman AJ, Urowitz MB, Ibañez D, Papneja A, Gladman DD. Prolonged clinical remission in patients with systemic lupus erythematosus. The Journal of Rheumatology. 41: 1808-16. PMID 25086082 DOI: 10.3899/jrheum.131137  0.52
2014 Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, et al. Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care & Research. 66: 1759-66. PMID 25047391 DOI: 10.1002/acr.22404  1
2014 Mease PJ, Gladman DD, Helliwell P, Khraishi MM, Fuiman J, Bananis E, Alvarez D. Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. Journal of the American Academy of Dermatology. 71: 649-55. PMID 24974240 DOI: 10.1016/j.jaad.2014.05.010  0.36
2014 Feagan BG, Choquette D, Ghosh S, Gladman DD, Ho V, Meibohm B, Zou G, Xu Z, Shankar G, Sealey DC, Russell AS. The challenge of indication extrapolation for infliximab biosimilars. Biologicals : Journal of the International Association of Biological Standardization. 42: 177-83. PMID 24962198 DOI: 10.1016/j.biologicals.2014.05.005  1
2014 Mease PJ, Garg A, Helliwell PS, Park JJ, Gladman DD. Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting. The Journal of Rheumatology. 41: 1249-51. PMID 24882864 DOI: 10.3899/jrheum.140182  0.32
2014 Gottlieb AB, Armstrong AW, Christensen R, Garg A, Duffin KC, Boehncke WH, Merola JF, Gladman DD, Mease PJ, Swerlick RA, Rosen CF, Abernethy A. The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting. The Journal of Rheumatology. 41: 1227-9. PMID 24882858 DOI: 10.3899/jrheum.140176  0.8
2014 de Wit M, Campbell W, FitzGerald O, Gladman DD, Helliwell PS, James J, Lindsay C, MacDonald R, McHugh NJ, Mease PJ, Orbai AM, Palominos P, Parkinson A, Tillett W, Goel N. Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting. The Journal of Rheumatology. 41: 1206-11. PMID 24882853 DOI: 10.3899/jrheum.140171  1
2014 Boehncke WH, Gladman DD. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. 41: 1194-6. PMID 24882850 DOI: 10.3899/jrheum.140168  1
2014 Eder L, Gladman DD, Ibañez D, Urowitz MB. The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients. Lupus. 23: 1142-8. PMID 24876099 DOI: 10.1177/0961203314537696  1
2014 Gladman DD, Abufayyah M, Abuffayah M, Salonen D, Thavaneswaran A, Chandran V. Radiological characteristics of the calcaneal spurs in psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 401-3. PMID 24850064  1
2014 Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Annals of the Rheumatic Diseases. PMID 24834926 DOI: 10.1136/annrheumdis-2013-205171  1
2014 Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 24827532 DOI: 10.1136/annrheumdis-2014-205267  1
2014 Al Maimouni H, Gladman DD, Ibañez D, Urowitz MB. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes. Arthritis Care & Research. 66: 1905-9. PMID 24821661 DOI: 10.1002/acr.22364  1
2014 Kavanaugh A, McInnes IB, Mease P, Krueger GG, Gladman D, van der Heijde D, Zhou Y, Lu J, Leu JH, Goldstein N, Beutler A. Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study). Annals of the Rheumatic Diseases. 73: 1689-94. PMID 24748630 DOI: 10.1136/annrheumdis-2013-204902  1
2014 Kennedy M, Papneja A, Thavaneswaran A, Chandran V, Gladman DD. Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 342-8. PMID 24708934  1
2014 Eder L, Gladman DD. Predictors for clinical outcome in psoriatic arthritis - what have we learned from cohort studies? Expert Review of Clinical Immunology. 10: 763-70. PMID 24702706 DOI: 10.1586/1744666X.2014.905741  1
2014 Urowitz MB, Gladman DD, Ibañez D, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Bae SC, Clarke AE, Bernatsky S, Fortin PR, Hanly JG, Isenberg D, Rahman A, Wallace DJ, Ginzler E, et al. American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort. The Journal of Rheumatology. 41: 875-80. PMID 24692526 DOI: 10.3899/jrheum.130704  1
2014 McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD. Depression and anxiety in psoriatic disease: prevalence and associated factors. The Journal of Rheumatology. 41: 887-96. PMID 24692521 DOI: 10.3899/jrheum.130797  1
2014 Biagioni BJ, Gladman DD, Cook RJ, Eder L, Wakhlu A, Shen H, Chandran V. Reliability of radiographic scoring methods in axial psoriatic arthritis. Arthritis Care & Research. 66: 1417-22. PMID 24515627 DOI: 10.1002/acr.22308  1
2014 Coates LC, FitzGerald O, Mease PJ, Gladman DD, Strand V, Goel N, Campbell I, Krueger G, McHugh NJ, Helliwell PS. Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11. The Journal of Rheumatology. 41: 782-91. PMID 24488420 DOI: 10.3899/jrheum.131250  1
2014 Eder L, Jayakar J, Thavaneswaran A, Haddad A, Chandran V, Salonen D, Rosen CF, Gladman DD. Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? The Journal of Rheumatology. 41: 466-72. PMID 24488414 DOI: 10.3899/jrheum.130949  1
2014 Lertratanakul A, Wu P, Dyer A, Urowitz M, Gladman D, Fortin P, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Merrill J, Wallace DJ, et al. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care & Research. 66: 1167-76. PMID 24470118 DOI: 10.1002/acr.22291  1
2014 Touma Z, Urowitz MB, Ibañez D, Gladman DD. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment. The Journal of Rheumatology. 41: 688-97. PMID 24429170 DOI: 10.3899/jrheum.130005  1
2014 Scinocca M, Bell DA, Racapé M, Joseph R, Shaw G, McCormick JK, Gladman DD, Pope J, Barra L, Cairns E. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides. The Journal of Rheumatology. 41: 270-9. PMID 24429169 DOI: 10.3899/jrheum.130742  1
2014 Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis. Rheumatology (Oxford, England). 53: 233-9. PMID 24185760 DOI: 10.1093/rheumatology/ket296  1
2014 Tselios K, Koumaras C, Urowitz MB, Gladman DD. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal. Seminars in Arthritis and Rheumatism. 43: 521-5. PMID 23953498 DOI: 10.1016/j.semarthrit.2013.07.007  1
2014 Eder L, Chandran V, Gladman DD. The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Annals of the Rheumatic Diseases. 73: 1990-6. PMID 23887287 DOI: 10.1136/annrheumdis-2013-203433  1
2014 Eder L, Thavaneswaran A, Chandran V, Gladman DD. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 73: 1007-11. PMID 23619157 DOI: 10.1136/annrheumdis-2012-202959  1
2014 Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin JF, Costenbader KH, Urowitz MB, Gladman DD, Fortin PR, Nived O, Petri MA, Jacobsen S, Manzi S, Ginzler EM, Isenberg D, Rahman A, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Annals of the Rheumatic Diseases. 73: 138-42. PMID 23303389 DOI: 10.1136/annrheumdis-2012-202099  1
2014 Gladman DD, Chandran V. Management of psoriatic arthritis Rheumatology: Sixth Edition. 2: 1008-1013. DOI: 10.1016/B978-0-323-09138-1.00122-4  1
2013 Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, ... ... Gladman DD, et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis and Rheumatism. 65: 2887-97. PMID 24166793 DOI: 10.1002/art.38106  1
2013 Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus. The Journal of Rheumatology. 40: 2006-14. PMID 24128779 DOI: 10.3899/jrheum.121273  1
2013 Lu M, Bernatsky S, Ramsey-Goldman R, Petri M, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler EM, Yelin E, Bae SC, Wallace DJ, Jacobsen S, Dooley MA, Peschken CA, et al. Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology. 85: 235-40. PMID 24107608 DOI: 10.1159/000350165  1
2013 Nikpour M, Gladman DD, Urowitz MB. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? Lupus. 22: 1243-50. PMID 24097996 DOI: 10.1177/0961203313493031  1
2013 Eder L, Urowitz MB, Gladman DD. Damage in lupus patients--what have we learned so far? Lupus. 22: 1225-31. PMID 24097994 DOI: 10.1177/0961203313492872  1
2013 Uddin M, Maksymowych WP, Inman R, Gladman D, Munn A, Yazdani R, Pellett F, Hamilton S, O'Rielly DD, Rahman P. UGT2B17 copy number gain in a large ankylosing spondylitis multiplex family. Bmc Genetics. 14: 67. PMID 23927372 DOI: 10.1186/1471-2156-14-67  1
2013 Chandran V, Bull SB, Pellett FJ, Ayearst R, Rahman P, Gladman DD. Human leukocyte antigen alleles and susceptibility to psoriatic arthritis. Human Immunology. 74: 1333-8. PMID 23916976 DOI: 10.1016/j.humimm.2013.07.014  1
2013 Mease PJ, Garg A, Gladman DD, Helliwell PS. Development of simple clinical criteria for the definition of inflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2012 annual meeting. The Journal of Rheumatology. 40: 1442-5. PMID 23908542 DOI: 10.3899/jrheum.130459  0.32
2013 Gladman DD, Helliwell PS, Khraishi M, Callis Duffin K, Mease PJ. Dermatology screening tools: project update from the GRAPPA 2012 annual meeting. The Journal of Rheumatology. 40: 1425-7. PMID 23908538 DOI: 10.3899/jrheum.130455  0.32
2013 Chandran V, Gladman DD, Helliwell PS, Gudbjörnsson B. Arthritis mutilans: a report from the GRAPPA 2012 annual meeting. The Journal of Rheumatology. 40: 1419-22. PMID 23908536 DOI: 10.3899/jrheum.130453  1
2013 Mease PJ, Boehncke WH, Gladman DD. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. 40: 1407-9. PMID 23908533 DOI: 10.3899/jrheum.130450  0.56
2013 Gladman DD, Ziouzina O, Thavaneswaran A, Chandran V. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. The Journal of Rheumatology. 40: 1357-9. PMID 23818708 DOI: 10.3899/jrheum.130163  1
2013 Haddad A, Thavaneswaran A, Toloza S, Chandran V, Gladman DD. Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis. The Journal of Rheumatology. 40: 1367-73. PMID 23772085 DOI: 10.3899/jrheum.121433  1
2013 Husted JA, Thavaneswaran A, Chandran V, Gladman DD. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. The Journal of Rheumatology. 40: 1349-56. PMID 23772076 DOI: 10.3899/jrheum.121500  1
2013 Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, Cremin K, Pryce K, Harris J, Lee S, Joo KB, Shim SC, Weisman M, Ward M, ... ... Gladman DD, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nature Genetics. 45: 730-8. PMID 23749187 DOI: 10.1038/ng.2667  1
2013 Touma Z, Urowitz MB, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50 website. The Journal of Rheumatology. 40: 733. PMID 23637378 DOI: 10.3899/jrheum.130030  1
2013 Chandran V, Shen H, Pollock RA, Pellett FJ, Carty A, Cook RJ, Gladman DD. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. The Journal of Rheumatology. 40: 866-71. PMID 23637322 DOI: 10.3899/jrheum.121162  1
2013 Pollock RA, Chandran V, Pellett FJ, Thavaneswaran A, Eder L, Barrett J, Rahman P, Farewell V, Gladman DD. The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. Tissue Antigens. 82: 43-7. PMID 23611695 DOI: 10.1111/tan.12126  1
2013 Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. The Journal of Rheumatology. 40: 831-41. PMID 23588942 DOI: 10.3899/jrheum.120572  1
2013 Coates LC, FitzGerald O, Gladman DD, McHugh N, Mease P, Strand V, Helliwell PS. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis and Rheumatism. 65: 1504-9. PMID 23529837 DOI: 10.1002/art.37939  1
2013 Gladman DD, Ibañez D, Ruiz I, Urowitz MB. Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study. The Journal of Rheumatology. 40: 630-3. PMID 23457385 DOI: 10.3899/jrheum.121094  1
2013 Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. Journal of Autoimmunity. 42: 130-5. PMID 23410586 DOI: 10.1016/j.jaut.2012.12.009  1
2013 Al-Maini M, Jeyalingam T, Brown P, Lee JJ, Li L, Su J, Gladman DD, Fortin PR. A hot spot for systemic lupus erythematosus, but not for psoriatic arthritis, identified by spatial analysis suggests an interaction between ethnicity and place of residence. Arthritis and Rheumatism. 65: 1579-85. PMID 23400685 DOI: 10.1002/art.37897  1
2013 Eder L, Gladman DD. Psoriatic arthritis: phenotypic variance and nosology. Current Rheumatology Reports. 15: 316. PMID 23371481 DOI: 10.1007/s11926-013-0316-4  1
2013 Touma Z, Gladman DD, Urowitz MB. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign. Current Opinion in Rheumatology. 25: 164-70. PMID 23370371 DOI: 10.1097/BOR.0b013e32835d2b7b  1
2013 Touma Z, Urowitz MB, Gladman DD. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions. Expert Opinion On Biological Therapy. 13: 723-37. PMID 23339281 DOI: 10.1517/14712598.2013.764411  1
2013 Touma Z, Haddad A, Gladman DD, Uleryk EM, Urowitz MB. Skin nontuberculous mycobacterial infection in systemic lupus erythematosus: an unusual skin infection mimicking lupus vasculitis. Seminars in Arthritis and Rheumatism. 42: 498-506. PMID 23332736 DOI: 10.1016/j.semarthrit.2012.08.002  1
2013 Chaudhry SR, Thavaneswaran A, Chandran V, Gladman DD. Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis. Rheumatology (Oxford, England). 52: 705-11. PMID 23267168 DOI: 10.1093/rheumatology/kes355  1
2013 Venner AA, Ibañez D, Gladman DD, Urowitz MB, MacKinnon A, Blasutig IM, Yip PM. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity. Clinical Biochemistry. 46: 317-20. PMID 23246539 DOI: 10.1016/j.clinbiochem.2012.12.004  1
2013 Eder L, Jayakar J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, Rosen CF, Gladman DD. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Annals of the Rheumatic Diseases. 72: 1956-61. PMID 23243196 DOI: 10.1136/annrheumdis-2012-202325  1
2013 Touma Z, Gladman DD, MacKinnon A, Carette S, Abu-Shakra M, Askanase A, Nived O, Hanly JG, Landolt-Marticorena C, Tam LS, Toloza S, Nikpour M, Riddell C, Steiman A, Eder L, et al. Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 website. The Journal of Rheumatology. 40: 34-9. PMID 23118108 DOI: 10.3899/jrheum.120754  1
2013 Eissa A, Cretu D, Soosaipillai A, Thavaneswaran A, Pellett F, Diamandis A, Cevikbas F, Steinhoff M, Diamandis EP, Gladman D, Chandran V. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clinical Chemistry and Laboratory Medicine. 51: 317-25. PMID 23096109 DOI: 10.1515/cclm-2012-0251  1
2013 Eder L, Barzilai M, Peled N, Gladman DD, Zisman D. The use of ultrasound for the assessment of enthesitis in patients with spondyloarthritis. Clinical Radiology. 68: 219-23. PMID 22959850 DOI: 10.1016/j.crad.2012.07.018  1
2013 Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, et al. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases. 72: 1308-14. PMID 22945501 DOI: 10.1136/annrheumdis-2012-202106  1
2013 Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Annals of the Rheumatic Diseases. 72: 986-91. PMID 22798567 DOI: 10.1136/annrheumdis-2012-201341  1
2013 Eder L, Jayakar J, Shanmugarajah S, Thavaneswaran A, Pereira D, Chandran V, Rosen CF, Gladman DD. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Annals of the Rheumatic Diseases. 72: 715-20. PMID 22736087 DOI: 10.1136/annrheumdis-2012-201497  1
2013 Eder L, Thavaneswaran A, Chandran V, Gladman DD. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 72: 578-82. PMID 22589379 DOI: 10.1136/annrheumdis-2012-201357  1
2013 Touma Z, Urowitz MB, Gladman DD. Outcome measures in systemic lupus erythematosus Indian Journal of Rheumatology. 8. DOI: 10.1016/j.injr.2013.11.015  1
2012 Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, ... ... Gladman DD, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics. 44: 1341-8. PMID 23143594 DOI: 10.1038/ng.2467  1
2012 Garg A, Gladman DD, Mease PJ. On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting. The Journal of Rheumatology. 39: 2214-5. PMID 23118291 DOI: 10.3899/jrheum.120827  1
2012 Helliwell PS, Fitzgerald O, Mease PJ, Gladman DD. GRAPPA Responder Index Project (GRACE): a report from the GRAPPA 2011 annual meeting. The Journal of Rheumatology. 39: 2196-7. PMID 23118286 DOI: 10.3899/jrheum.120822  0.32
2012 Gladman DD. Biomarkers for comorbidities in psoriasis: a report from the GRAPPA 2011 annual meeting. The Journal of Rheumatology. 39: 2193-5. PMID 23118285 DOI: 10.3899/jrheum.120821  1
2012 Mease PJ, Gladman DD. Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. 39: 2181-3. PMID 23118282 DOI: 10.3899/jrheum.120818  1
2012 Gladman DD, Chandran V, Thavaneswaran A, Zummer M. Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology. The Journal of Rheumatology. 39: 1850-3. PMID 22859361 DOI: 10.3899/jrheum.120282  1
2012 Gladman DD. Early psoriatic arthritis. Rheumatic Diseases Clinics of North America. 38: 373-86. PMID 22819090 DOI: 10.1016/j.rdc.2012.05.005  1
2012 Touma Z, Gladman DD, Ibañez D, Urowitz MB. SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years. Lupus. 21: 1305-11. PMID 22800940 DOI: 10.1177/0961203312454344  1
2012 Gladman DD. Future trends in research in psoriatic arthritis. The Journal of Rheumatology. Supplement. 89: 106-10. PMID 22751608 DOI: 10.3899/jrheum.120259  1
2012 Touma Z, Urowitz MB, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Rheumatology (Oxford, England). 51: 1814-9. PMID 22718868 DOI: 10.1093/rheumatology/kes146  1
2012 Nikpour M, Harvey PJ, Ibanez D, Gladman DD, Urowitz MB. High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus. Arthritis and Rheumatism. 64: 3052-3. PMID 22614710 DOI: 10.1002/art.34541  1
2012 Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Seminars in Arthritis and Rheumatism. 42: 179-85. PMID 22595642 DOI: 10.1016/j.semarthrit.2012.03.011  1
2012 Eder L, Chandran V, Pellett F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study. Annals of the Rheumatic Diseases. 71: 1361-5. PMID 22586163 DOI: 10.1136/annrheumdis-2012-201308  1
2012 Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, ... ... Gladman D, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and Rheumatism. 64: 2677-86. PMID 22553077 DOI: 10.1002/art.34473  1
2012 Gladman DD, Urowitz MB. University of Toronto Lupus Clinic turns 40. The Journal of Rheumatology. 39: 1074-7. PMID 22550007 DOI: 10.3899/jrheum.111581  1
2012 Jordan CT, Cao L, Roberson ED, Duan S, Helms CA, Nair RP, Duffin KC, Stuart PE, Goldgar D, Hayashi G, Olfson EH, Feng BJ, Pullinger CR, Kane JP, Wise CA, ... ... Gladman D, et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. American Journal of Human Genetics. 90: 796-808. PMID 22521419 DOI: 10.1016/j.ajhg.2012.03.013  1
2012 Touma Z, Thavaneswaran A, Chandran V, Gladman DD. Does the change in season affect disease activity in patients with psoriatic arthritis? Annals of the Rheumatic Diseases. 71: 1370-3. PMID 22504562 DOI: 10.1136/annrheumdis-2011-201208  1
2012 Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G, Yip J, Nasr SH, Thomas D, Scholey JW, Wither J, Urowitz M, Gladman D, Reich H, Fortin PR. Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 757-64. PMID 22442181 DOI: 10.2215/CJN.02870311  1
2012 Gladman DD, Ritchlin CT, Fitzgerald O. The path forward to biomarker discovery in psoriatic disease: a report from the GRAPPA 2010 annual meeting. The Journal of Rheumatology. 39: 434-6. PMID 22298275 DOI: 10.3899/jrheum.111243  1
2012 Gladman DD. Inflammatory spinal disease in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. The Journal of Rheumatology. 39: 418-20. PMID 22298270 DOI: 10.3899/jrheum.111238  1
2012 Garg A, Gladman DD, Mease PJ. The need to define musculoskeletal inflammation: a report from the GRAPPA 2010 annual meeting. The Journal of Rheumatology. 39: 413-4. PMID 22298268 DOI: 10.3899/jrheum.111236  1
2012 Mease PJ, Gladman DD. Prologue: 2010 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. 39: 391-3. PMID 22298263 DOI: 10.3899/jrheum.111231  1
2012 Wang M, Gladman DD, Ibañez D, Urowitz MB. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Arthritis Care & Research. 64: 833-7. PMID 22290935 DOI: 10.1002/acr.21624  1
2012 Eder L, Thavaneswaran A, Pereira D, Sussman G, Gladman DD. Prevalence of monoclonal gammopathy among patients with psoriatic arthritis. The Journal of Rheumatology. 39: 564-7. PMID 22247355 DOI: 10.3899/jrheum.111054  1
2012 Husted JA, Tom BD, Farewell VT, Gladman DD. Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis. Arthritis Care & Research. 64: 758-65. PMID 22231988 DOI: 10.1002/acr.21602  0.8
2012 Huang D, Aghdassi E, Su J, Mosko J, Hirschfield GM, Gladman DD, Urowitz MB, Fortin PR. Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. The Journal of Rheumatology. 39: 254-61. PMID 22174205 DOI: 10.3899/jrheum.110310  1
2012 Ellinghaus E, Stuart PE, Ellinghaus D, Nair RP, Debrus S, Raelson JV, Belouchi M, Tejasvi T, Li Y, Tsoi LC, Onken AT, Esko T, Metspalu A, Rahman P, Gladman DD, et al. Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. The Journal of Investigative Dermatology. 132: 1133-40. PMID 22170493 DOI: 10.1038/jid.2011.415  1
2012 Steiman AJ, Gladman DD, Ibañez D, Urowitz MB. Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period. Arthritis Care & Research. 64: 511-8. PMID 22162433 DOI: 10.1002/acr.21568  1
2012 Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford, England). 51: 571-6. PMID 22157469 DOI: 10.1093/rheumatology/ker365  1
2012 Touma Z, Gladman DD, Ibañez D, Urowitz MB. Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients. Rheumatology (Oxford, England). 51: 528-34. PMID 22120460 DOI: 10.1093/rheumatology/ker339  1
2012 Tejasvi T, Stuart PE, Chandran V, Voorhees JJ, Gladman DD, Rahman P, Elder JT, Nair RP. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. The Journal of Investigative Dermatology. 132: 593-600. PMID 22113471 DOI: 10.1038/jid.2011.376  1
2012 Eder L, Shanmugarajah S, Thavaneswaran A, Chandran V, Rosen CF, Cook RJ, Gladman DD. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Annals of the Rheumatic Diseases. 71: 219-24. PMID 21953342 DOI: 10.1136/ard.2010.147793  1
2012 Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Annals of the Rheumatic Diseases. 71: 50-5. PMID 21900282 DOI: 10.1136/ard.2011.155044  1
2012 Eder L, Chandran V, Gladman DD. Dr. Eder, et al, reply Journal of Rheumatology. 39: 186. DOI: 10.3899/jrheum.110828  1
2012 Eder L, Chandran V, Gladman DD. Gender-related differences in patients with psoriatic arthritis International Journal of Clinical Rheumatology. 7: 641-649. DOI: 10.2217/ijr.12.63  1
2012 Gladman DD, Thavaneswaran A, Chandran V. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? (Annals of the Rheumatic Diseases (2011) 70, (2152-2154)) Annals of the Rheumatic Diseases. 71: 1592. DOI: 10.1136/ard.2011.150938corr1  1
2012 Touma Z, Gladman DD, Urowitz MB. Clinical Measures, Metrics, and Indices Dubois' Lupus Erythematosus and Related Syndromes: Eighth Edition. 563-581. DOI: 10.1016/B978-1-4377-1893-5.00046-7  1
2011 Touma Z, Eder L, Zisman D, Feld J, Chandran V, Rosen CF, Shen H, Cook RJ, Gladman DD. Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care & Research. 63: 1440-7. PMID 22121512 DOI: 10.1002/acr.20530  1
2011 MacKenzie H, Thavaneswaran A, Chandran V, Gladman DD. Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. The Journal of Rheumatology. 38: 2619-24. PMID 22045844 DOI: 10.3899/jrheum.110165  1
2011 Urowitz MB, Anton A, Ibanez D, Gladman DD. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus. Arthritis Care & Research. 63: 1517-20. PMID 22034113 DOI: 10.1002/acr.20599  1
2011 Nikpour M, Urowitz MB, Ibanez D, Harvey PJ, Gladman DD. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Research & Therapy. 13: R156. PMID 21955652 DOI: 10.1186/ar3473  1
2011 Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Annals of the Rheumatic Diseases. 70: 2152-4. PMID 21914627 DOI: 10.1136/ard.2011.150938  1
2011 Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care & Research. 63: 1729-35. PMID 21905258 DOI: 10.1002/acr.20627  1
2011 Touma Z, Gladman DD, Ibañez D, Taghavi-Zadeh S, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials. The Journal of Rheumatology. 38: 2395-9. PMID 21885488 DOI: 10.3899/jrheum.110550  1
2011 Barber CE, Leclerc R, Gladman DD, Urowitz MB, Fortin PR. Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 41: 353-63. PMID 21868061 DOI: 10.1016/j.semarthrit.2011.07.001  1
2011 Lui NL, Haroon N, Carty A, Shen H, Cook RJ, Shanmugarajah S, Gladman DD, Inman RD. Effect of pregnancy on ankylosing spondylitis: a case-control study. The Journal of Rheumatology. 38: 2442-4. PMID 21844140 DOI: 10.3899/jrheum.101174  1
2011 Davis AM, Palaganas MP, Badley EM, Gladman DD, Inman RD, Gignac MA. Measuring participation in people with spondyloarthritis using the social role participation questionnaire. Annals of the Rheumatic Diseases. 70: 1765-9. PMID 21791450 DOI: 10.1136/ard.2010.149211  1
2011 Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianas L, Moutsianis L, Leslie S, ... ... Gladman D, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics. 43: 761-7. PMID 21743469 DOI: 10.1038/ng.873  1
2011 Coates LC, Mumtaz A, Helliwell PS, Mease PJ, Callis-Duffin K, Krueger GG, McHugh NJ, Strand V, Gladman DD, FitzGerald O. Development of a disease severity and responder index for Psoriatic Arthritis (PsA) - Report of the OMERACT 10 PsA special interest group Journal of Rheumatology. 38: 1496-1501. PMID 21724722 DOI: 10.3899/jrheum.110278  1
2011 Touma Z, Gladman DD, Ibañez D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? The Journal of Rheumatology. 38: 1898-905. PMID 21724700 DOI: 10.3899/jrheum.110007  1
2011 Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 41: 203-11. PMID 21641018 DOI: 10.1016/j.semarthrit.2011.04.001  0.44
2011 Eder L, Chandran V, Pellett F, Pollock R, Shanmugarajah S, Rosen CF, Rahman P, Gladman DD. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Annals of the Rheumatic Diseases. 70: 1594-8. PMID 21613309 DOI: 10.1136/ard.2010.147421  1
2011 Gladman DD, Bombardier C, Thorne C, Haraoui B, Khraishi M, Rahman P, Bensen W, Syrotuik J, Poulin-Costello M. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial. The Journal of Rheumatology. 38: 1355-62. PMID 21572156 DOI: 10.3899/jrheum.100698  1
2011 Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, Cook RJ, Gladman DD. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care & Research. 63: 1091-7. PMID 21560259 DOI: 10.1002/acr.20496  1
2011 Gladman DD, Rahman P, Cook RJ, Shen H, Zummer M, Thomson G, Nair B, Rohekar S, Ayearst R, Inman RD, Maksymowych WP. The Spondyloarthritis Research Consortium of Canada registry for spondyloarthritis. The Journal of Rheumatology. 38: 1343-8. PMID 21498484 DOI: 10.3899/jrheum.101102  1
2011 Gladman DD, Chandran V. Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future? Current Rheumatology Reports. 13: 346-52. PMID 21494786 DOI: 10.1007/s11926-011-0182-x  1
2011 Pollock R, Chandran V, Barrett J, Eder L, Pellett F, Yao C, Lino M, Shanmugarajah S, Farewell VT, Gladman DD. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens. 77: 554-61. PMID 21457151 DOI: 10.1111/j.1399-0039.2011.01670.x  1
2011 Eder L, Chandran V, Shen H, Cook RJ, Shanmugarajah S, Rosen CF, Gladman DD. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care & Research. 63: 619-22. PMID 21452273 DOI: 10.1002/acr.20401  1
2011 Aghdassi E, Ma DW, Morrison S, Hillyer LM, Clarke S, Gladman DD, Urowitz MB, Fortin PR. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. Jpen. Journal of Parenteral and Enteral Nutrition. 35: 198-208. PMID 21378249 DOI: 10.1177/0148607110386378  0.44
2011 Boehncke WH, Gladman DD, Chandran V. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting. The Journal of Rheumatology. 38: 567-71. PMID 21362790 DOI: 10.3899/jrheum.101124  1
2011 Chandran V, Gladman DD. Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting. The Journal of Rheumatology. 38: 546-7. PMID 21362783 DOI: 10.3899/jrheum.101117  1
2011 Mease PJ, Gladman DD. Prologue: 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Journal of Rheumatology. 38: 522-525. PMID 21362779 DOI: 10.3899/jrheum.101113  1
2011 Balitsky AK, Peeva V, Su J, Aghdassi E, Yeo E, Gladman DD, Urowitz MB, Fortin PR. Thrombovascular events affect quality of life in patients with systemic lupus erythematosus. The Journal of Rheumatology. 38: 1017-9. PMID 21362766 DOI: 10.3899/jrheum.101054  0.44
2011 Eder L, Chandran V, Gladman DD. Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods. The Journal of Rheumatology. 38: 1066-70. PMID 21324963 DOI: 10.3899/jrheum.100919  1
2011 Touma Z, Urowitz MB, Fortin PR, Landolt C, Toloza SM, Riddell C, Chandran V, Eder L, Ghanem A, Ziouzina O, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. The Journal of Rheumatology. 38: 868-73. PMID 21324961 DOI: 10.3899/jrheum.101080  1
2011 Reich HN, Gladman DD, Urowitz MB, Bargman JM, Hladunewich MA, Lou W, Fan SC, Su J, Herzenberg AM, Cattran DC, Wither J, Landolt-Marticorena C, Scholey JW, Fortin PR. Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney International. 79: 914-20. PMID 21248713 DOI: 10.1038/ki.2010.525  1
2011 Rahman P, Roslin NM, Pellett FJ, Lemire M, Greenwood CM, Beyene J, Pope A, Peddle L, Paterson AD, Uddin M, Gladman DD. High resolution mapping in the major histocompatibility complex region identifies multiple independent novel loci for psoriatic arthritis. Annals of the Rheumatic Diseases. 70: 690-4. PMID 21242233 DOI: 10.1136/ard.2010.133561  1
2011 Landolt-Marticorena C, Wither R, Reich H, Herzenberg A, Scholey J, Gladman DD, Urowitz MB, Fortin PR, Wither J. Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus. The Journal of Rheumatology. 38: 642-51. PMID 21239754 DOI: 10.3899/jrheum.100214  1
2011 Touma Z, Urowitz MB, Ibañez D, Gladman DD. SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus. 20: 67-70. PMID 21233149 DOI: 10.1177/0961203310385163  1
2011 Zhang W, Aghdassi E, Reich HN, Su J, Lou W, Landolt-Marticorena C, Gladman DD, Urowitz MB, Scholey J, Fortin PR. Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus. Rheumatology (Oxford, England). 50: 799-805. PMID 21156670 DOI: 10.1093/rheumatology/keq383  1
2011 Touma Z, Gladman DD, Ibañez D, Urowitz MB. Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50. The Journal of Rheumatology. 38: 275-84. PMID 21123323 DOI: 10.3899/jrheum.100724  1
2011 Nikpour M, Urowitz MB, Ibañez D, Gladman DD. Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus. Lupus. 20: 299-304. PMID 21078763 DOI: 10.1177/0961203310381512  1
2011 Bernatsky S, Peschken C, Fortin PR, Pineau CA, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE. Medication use in systemic lupus erythematosus. The Journal of Rheumatology. 38: 271-4. PMID 21078722 DOI: 10.3899/jrheum.100414  0.64
2011 Ibañez D, Gladman DD, Touma Z, Nikpour M, Urowitz MB. Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time. The Journal of Rheumatology. 38: 60-3. PMID 21078718 DOI: 10.3899/jrheum.100575  1
2011 Cresswell L, Chandran V, Farewell VT, Gladman DD. Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis. Annals of the Rheumatic Diseases. 70: 305-8. PMID 20980703 DOI: 10.1136/ard.2010.135087  1
2011 Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, et al. A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes and Immunity. 12: 51-8. PMID 20962850 DOI: 10.1038/gene.2010.47  1
2011 Touma Z, Gladman DD, Urowitz MB, Beyene J, Uleryk EM, Shah PS. Mycophenolate mofetil for induction treatment of lupus nephritis: A systematic review and metaanalysis Journal of Rheumatology. 38: 69-78. PMID 20952473 DOI: 10.3899/jrheum.100130  1
2011 Isenberg DA, Allen E, Farewell V, D'Cruz D, Alarcón GS, Aranow C, Bruce IN, Dooley MA, Fortin PR, Ginzler EM, Gladman DD, Hanly JG, Inanc M, Kalunian K, Khamashta M, et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Annals of the Rheumatic Diseases. 70: 54-9. PMID 20833737 DOI: 10.1136/ard.2010.132068  1
2011 Gladman DD, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford, England). 50: 25-31. PMID 20693260 DOI: 10.1093/rheumatology/keq262  1
2011 Evans DM, Reveille JD, Brown M, Chandran V, Gladman DD, Martin TM, McGovern D, Wordsworth P, Inman RD. The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009 (Journal of Rheumatology (2010) 37 (2626-2631)) Journal of Rheumatology. 38: 788. DOI: 10.3899/jrheum.100892C1  1
2011 Gladman DD, Chandran V. Standardizing the monitoring of outcome measures: Imaging in psoriatic arthritis International Journal of Clinical Rheumatology. 6: 77-86. DOI: 10.2217/ijr.10.103  1
2010 Evans DM, Reveille JD, Brown MA, Chandran V, Gladman DD, Martin TM, McGovern D, Wordsworth P, Inman RD. The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009. The Journal of Rheumatology. 37: 2626-31. PMID 21123336 DOI: 10.3899/jrheum.100892  1
2010 Weisman M, Learch TJ, Baraliakos X, Chandran V, Gladman DD, Raychaudhuri SP, Xu H, Collantes-Estévez E, Vázquez-Mellado J, Mease PJ, Sieper J, Deodhar AA, Colbert RA, Clegg DO. Current controversies in spondyloarthritis: SPARTAN. The Journal of Rheumatology. 37: 2617-23. PMID 21123334 DOI: 10.3899/jrheum.100890  1
2010 Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE, Li Y, Weidinger S, Eberlein B, Gieger C, Wichmann HE, Kunz M, Ike R, Krueger GG, Bowcock AM, ... ... Gladman DD, et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nature Genetics. 42: 1000-4. PMID 20953189 DOI: 10.1038/ng.693  1
2010 Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, Belouchi M, Fournier H, Reinhard C, Ding J, Li Y, Tejasvi T, Gudjonsson J, Stoll SW, Voorhees JJ, ... ... Gladman DD, et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nature Genetics. 42: 991-5. PMID 20953188 DOI: 10.1038/ng.689  1
2010 Garg A, Gladman D. Recognizing psoriatic arthritis in the dermatology clinic Journal of the American Academy of Dermatology. 63: 733-748. PMID 20950737 DOI: 10.1016/j.jaad.2010.02.061  1
2010 Eder L, Chandran V, Shen H, Cook RJ, Gladman DD. Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Annals of the Rheumatic Diseases. 69: 2160-4. PMID 20627946 DOI: 10.1136/ard.2010.129726  1
2010 Steiman AJ, Gladman DD, Ibañez D, Urowitz MB. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome. The Journal of Rheumatology. 37: 1822-7. PMID 20595281 DOI: 10.3899/jrheum.100007  1
2010 Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study. Arthritis Research & Therapy. 12: R125. PMID 20591138 DOI: 10.1186/ar3063  1
2010 Zhu LJ, Landolt-Marticorena C, Li T, Yang X, Yu XQ, Gladman DD, Urowitz MB, Fortin PR, Wither JE. Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus. The Journal of Rheumatology. 37: 1658-66. PMID 20516030 DOI: 10.3899/jrheum.091123  1
2010 Yip J, Aghdassi E, Su J, Lou W, Reich H, Bargman J, Scholey J, Gladman DD, Urowitz MB, Fortin PR. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. The Journal of Rheumatology. 37: 1667-72. PMID 20516026 DOI: 10.3899/jrheum.091028  1
2010 Chandran V, Siannis F, Rahman P, Pellett FJ, Farewell VT, Gladman DD. Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis. The Journal of Rheumatology. 37: 1508-12. PMID 20472929 DOI: 10.3899/jrheum.091311  1
2010 Chandran V, Gladman DD. Update on biomarkers in psoriatic arthritis. Current Rheumatology Reports. 12: 288-94. PMID 20437120 DOI: 10.1007/s11926-010-0107-0  1
2010 Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, Rosen CF, Gladman DD. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford, England). 49: 1399-405. PMID 20421218 DOI: 10.1093/rheumatology/keq105  1
2010 Eder L, Chandran V, Ueng J, Bhella S, Lee KA, Rahman P, Pope A, Cook RJ, Gladman DD. Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford, England). 49: 1367-73. PMID 20388640 DOI: 10.1093/rheumatology/keq102  1
2010 Eder L, Chandran V, Schentag CT, Shen H, Cook RJ, Gladman DD. Time and predictors of response to tumour necrosis factor-alpha blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort. Rheumatology (Oxford, England). 49: 1361-6. PMID 20385615 DOI: 10.1093/rheumatology/keq091  1
2010 Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. The Journal of Rheumatology. 37: 809-15. PMID 20231209 DOI: 10.3899/jrheum.091059  1
2010 Coates LC, Cook R, Lee KA, Chandran V, Gladman DD. Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care & Research. 62: 970-6. PMID 20191569 DOI: 10.1002/acr.20162  1
2010 Coates LC, McGonagle DM, Hodgson R, Gisondi P, Kavanaugh AF, Qureshi AA, Fitzgerald O, Mease PJ, Garg A, Rosen CF, Ridley D, Gladman DD, Krueger GG, Ritchlin CT, Helliwell PS. Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. The Journal of Rheumatology. 37: 448-52. PMID 20147480 DOI: 10.3899/jrheum.090955  0.8
2010 Gladman DD. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2008 Journal of Rheumatology. 37: 446-447. PMID 20147479 DOI: 10.3899/jrheum.090954  1
2010 Gladman DD. Etanercept for psoriatic arthritis Bmj (Online). 340: 272. PMID 20124564 DOI: 10.1136/bmj.c229  1
2010 Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, et al. Clinical and serologic factors associated with lupus pleuritis. The Journal of Rheumatology. 37: 747-53. PMID 20110526 DOI: 10.3899/jrheum.090249  1
2010 Aghdassi E, Morrison S, Landolt-Marticorena C, Su J, Pineau CA, Gladman D, Urowitz M, Pope J, Peschken C, Dacosta D, Wither J, Fortin PR. The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus. The Journal of Rheumatology. 37: 87-90. PMID 19955051 DOI: 10.3899/jrheum.090761  1
2010 Touma Z, Urowitz MB, Gladman DD. SLEDAI-2K for a 30-day window. Lupus. 19: 49-51. PMID 19910390 DOI: 10.1177/0961203309346505  1
2010 Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus. 19: 13-9. PMID 19897520 DOI: 10.1177/0961203309345775  0.44
2010 Eder L, Sadek M, McDonald-Blumer H, Gladman DD. Aortitis and spondyloarthritis--an unusual presentation: case report and review of the literature. Seminars in Arthritis and Rheumatism. 39: 510-4. PMID 19217648 DOI: 10.1016/j.semarthrit.2008.11.004  1
2010 Gladman DD. Management of Psoriatic Arthritis Targeted Treatment of the Rheumatic Diseases. 55-69. DOI: 10.1016/B978-1-4160-9993-2.00006-0  1
2010 Gladman DD, Callen JP. Early-onset obesity and risk for psoriatic arthritis Jama - Journal of the American Medical Association. 304: 787-788. DOI: 10.1001/jama.2010.1162  1
2009 Stone MA, White LM, Gladman DD, Inman RD, Chaya S, Lax M, Salonen D, Weber DA, Guthrie JA, Pomeroy E, Podbielski D, Keystone EC. Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imaging. The Journal of Rheumatology. 36: 2751-7. PMID 19918033 DOI: 10.3899/jrheum.080205  1
2009 Chandran V, Barrett J, Schentag CT, Farewell VT, Gladman DD. Axial psoriatic arthritis: update on a longterm prospective study. The Journal of Rheumatology. 36: 2744-50. PMID 19884276 DOI: 10.3899/jrheum.090412  1
2009 Eder L, Chandran V, Gladman DD. From ankylosis to pencil-in-cup deformity in psoriatic arthritis: A case report Clinical and Experimental Rheumatology. 27: 661-663. PMID 19772803  1
2009 Nikpour M, Gladman DD, Ibañez D, Urowitz MB. Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus. Lupus. 18: 966-73. PMID 19762397 DOI: 10.1177/0961203309105130  1
2009 Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen CF, ... ... Gladman DD, et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis and Rheumatism. 61: 1235-42. PMID 19714610 DOI: 10.1002/art.24562  1
2009 Nikpour M, Urowitz MB, Gladman DD. Epidemiology of atherosclerosis in systemic lupus erythematosus. Current Rheumatology Reports. 11: 248-54. PMID 19691927 DOI: 10.1007/s11926-009-0035-z  1
2009 Maksymowych WP, Fitzgerald O, Wells GA, Gladman DD, Landewé R, Ostergaard M, Taylor WJ, Christensen R, Tak PP, Boers M, Syversen SW, Bathon JM, Ritchlin CJ, Mease PJ, Bykerk VP, et al. Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design. The Journal of Rheumatology. 36: 1792-9. PMID 19671814 DOI: 10.3899/jrheum090347  1
2009 Maksymowych WP, Landewé R, Tak PP, Ritchlin CJ, Ostergaard M, Mease PJ, El-Gabalawy H, Garnero P, Gladman DD, Fitzgerald O, Aletaha D, Bykerk VP, Bathon JM, Syversen SW, Boers M, et al. Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria. The Journal of Rheumatology. 36: 1785-91. PMID 19671813 DOI: 10.3899/jrheum.090346  1
2009 Syversen SW, Landewe R, van der Heijde D, Bathon JM, Boers M, Bykerk VP, Fitzgerald O, Gladman DD, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus V, Kvien TK, Mease PJ, et al. Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers. The Journal of Rheumatology. 36: 1769-84. PMID 19671812 DOI: 10.3899/jrheum.090262  1
2009 Gladman DD. Psoriatic arthritis from Wright's Era until today Journal of Rheumatology. 36: 4-8. PMID 19661526 DOI: 10.3899/jrheum.090209  1
2009 Gladman DD. Spondyloarthropathies: Targeted therapy for psoriatic arthritis Nature Reviews. Rheumatology. 5: 241-242. PMID 19412187 DOI: 10.1038/nrrheum.2009.76  1
2009 Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis Arthritis and Rheumatism. 60: 1317-1323. PMID 19404951 DOI: 10.1002/art.24467  1
2009 Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga HO, Gladman DD, Urowitz M, Zummer M, Clarke A, Bernatsky S, Hudson M. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. The Journal of Rheumatology. 36: 1200-8. PMID 19369456 DOI: 10.3899/jrheum.080912  1
2009 Hochman J, Urowitz MB, Ibañz D, Gladman DD. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease Lupus. 18: 313-317. PMID 19276299 DOI: 10.1177/0961203308097475  1
2009 Nikpour M, Gladman DD, Ibañez D, Bruce IN, Burns RJ, Urowitz MB. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. The Journal of Rheumatology. 36: 288-94. PMID 19208561 DOI: 10.3899/jrheum.080776  1
2009 Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nature Genetics. 41: 199-204. PMID 19169254 DOI: 10.1038/ng.311  1
2009 Rahman P, Inman RD, Maksymowych WP, Reeve JP, Peddle L, Gladman DD. Association of interleukin 23 receptor variants with psoriatic arthritis. The Journal of Rheumatology. 36: 137-40. PMID 19040306 DOI: 10.3899/jrheum.080458  1
2009 Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH, de Vlam K, Fiorentino D, Fitzgerald O, Gottlieb AB, McHugh NJ, Nash P, Qureshi AA, Soriano ER, Taylor WJ, et al. Treatment recommendations for psoriatic arthritis. Annals of the Rheumatic Diseases. 68: 1387-94. PMID 18952643 DOI: 10.1136/ard.2008.094946  0.56
2009 Landolt-Marticorena C, Bonventi G, Lubovich A, Ferguson C, Unnithan T, Su J, Gladman DD, Urowitz M, Fortin PR, Wither J. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 68: 1440-6. PMID 18772188 DOI: 10.1136/ard.2008.093146  1
2009 Mease PJ, Ory P, Sharp JT, Ritchlin CT, Van den Bosch F, Wellborne F, Birbara C, Thomson GT, Perdok RJ, Medich J, Wong RL, Gladman DD. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Annals of the Rheumatic Diseases. 68: 702-9. PMID 18684743 DOI: 10.1136/ard.2008.092767  1
2009 Chandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM, Rahman P, Gladman DD. Familial aggregation of psoriatic arthritis. Annals of the Rheumatic Diseases. 68: 664-7. PMID 18524791 DOI: 10.1136/ard.2008.089367  1
2009 Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen C, Farewell VT. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Annals of the Rheumatic Diseases. 68: 497-501. PMID 18445625 DOI: 10.1136/ard.2008.089441  1
2008 Gladman DD, Brown RE. Pharmacoeconomics of adalimumab for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. Expert Review of Pharmacoeconomics & Outcomes Research. 8: 111-25. PMID 20528400 DOI: 10.1586/14737167.8.2.111  1
2008 Gladman DD. Mortality in psoriatic arthritis Clinical and Experimental Rheumatology. 26. PMID 19026145  1
2008 Gladman DD. Can we identify psoriatic arthritis early? Current Rheumatology Reports. 10: 419-421. PMID 19007529 DOI: 10.1007/s11926-008-0067-9  1
2008 Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. The Journal of Rheumatology. 35: 2069-70; author repl. PMID 18843760  1
2008 Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. The Journal of Rheumatology. 35: 2152-8. PMID 18793004 DOI: 10.3899/jrheum.080214  0.6
2008 Wither J, Cai YC, Lim S, McKenzie T, Roslin N, Claudio JO, Cooper GS, Hudson TJ, Paterson AD, Greenwood CM, Gladman D, Pope J, Pineau CA, Smith CD, Hanly JG, et al. Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Research & Therapy. 10: R108. PMID 18783591 DOI: 10.1186/ar2505  1
2008 Urowitz MB, Gladman DD. The SLICC inception cohort for atherosclerosis. Current Rheumatology Reports. 10: 281-5. PMID 18662507 DOI: 10.1007/s11926-008-0045-2  1
2008 Gladman DD. GRAPPA 2007: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis Journal of Rheumatology. 35: 1420-1422. PMID 18609736  1
2008 Urowitz MB, Gladman DD, MacKinnon A, Ibañez D, Bruto V, Rovet J, Silverman E. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus. 17: 555-60. PMID 18539709 DOI: 10.1177/0961203308089326  0.44
2008 Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, Hanly JG, Isenberg DA, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, ... ... Gladman DD, et al. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis and Rheumatism. 58: 1784-8. PMID 18512819 DOI: 10.1002/art.23456  1
2008 Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis and Rheumatism. 58: 1020-5. PMID 18383363 DOI: 10.1002/art.23389  1
2008 Kuriya B, Gladman DD, Ibañez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 59: 181-5. PMID 18240183 DOI: 10.1002/art.23339  1
2008 Chang NH, McKenzie T, Bonventi G, Landolt-Marticorena C, Fortin PR, Gladman D, Urowitz M, Wither JE. Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 180: 1276-84. PMID 18178868 DOI: 10.4049/jimmunol.180.2.1276  1
2008 Chandran V, Schentag CT, Gladman DD. Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort. The Journal of Rheumatology. 35: 469-71. PMID 18085735  1
2008 Nikpour M, Dempsey AA, Urowitz MB, Gladman DD, Barnes DA. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Annals of the Rheumatic Diseases. 67: 1069-75. PMID 18063674 DOI: 10.1136/ard.2007.074765  1
2008 Gladman DD. Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis Nature Clinical Practice Rheumatology. 4: 510-511. DOI: 10.1038/ncprheum0880  1
2008 Gladman DD. Psoriatic arthritis A. clinical features Primer On the Rheumatic Diseases: Thirteenth Edition. 170-177. DOI: 10.1007/978-0-387-68566-3_8  1
2007 Gladman DD. Axial disease in psoriatic arthritis Current Rheumatology Reports. 9: 455-460. PMID 18177598 DOI: 10.1007/s11926-007-0074-2  1
2007 Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis and Rheumatism. 57: 1560-3. PMID 18050230 DOI: 10.1002/art.23104  1
2007 Urowitz MB, Gladman DD. Atherosclerosis and lupus - The SLICC study Lupus. 16: 925-928. PMID 18042585 DOI: 10.1177/0961203307085259  1
2007 Chandran V, Pellett F, Gladman DD. Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis [6] Scandinavian Journal of Rheumatology. 36: 409. PMID 17963178 DOI: 10.1080/03009740701406601  1
2007 Gladman D. Biologic therapy of psoriatic arthritis Reumatismo. 59: 85-87. PMID 17828353 DOI: 10.4081/reumatismo.2007.1s.85  1
2007 Toloza S, Urowitz MB, Gladman DD. Should all patients with systemic lupus erythematosus receive cardioprotection with statins? Nature Clinical Practice. Rheumatology. 3: 536-7. PMID 17700557 DOI: 10.1038/ncprheum0593  1
2007 van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, Zhou B, Dooley LT, de Vlam K, Geusens P, Birbara C, Halter D, Beutler A. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis and Rheumatism. 56: 2698-707. PMID 17665424 DOI: 10.1002/art.22805  1
2007 Ali YM, Urowitz MB, Ibanez D, Gladman DD. Monoclonal gammopathy in systemic lupus erythematosus. Lupus. 16: 426-9. PMID 17664233 DOI: 10.1177/0961203307079045  1
2007 Prasad R, Ibanez D, Gladman D, Urowitz MB. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: A nested case-control study of inception patients Lupus. 16: 157-162. PMID 17432099 DOI: 10.1177/0961203306075771  1
2007 Davis JC, Gladman DD. Spinal mobility measures in spondyloarthritis: Application of the OMERACT filter Journal of Rheumatology. 34: 666-670. PMID 17407227  1
2007 Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 66: 936-9. PMID 17324972 DOI: 10.1136/ard.2006.065763  1
2007 Ibañez D, Gladman D, Urowitz M. Summarizing disease features over time: II. Variability measures of SLEDAI-2K Journal of Rheumatology. 34: 336-340. PMID 17183620  1
2007 Urowitz MB, Ibañez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. The Journal of Rheumatology. 34: 70-5. PMID 17117488  1
2007 Kavanaugh A, Krueger GG, Beutler A, Guzzo C, Zhou B, Dooley LT, Mease PJ, Gladman DD, de Vlam K, Geusens PP, Birbara C, Halter DG, Antoni C. Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Annals of the Rheumatic Diseases. 66: 498-505. PMID 17114188 DOI: 10.1136/ard.2006.058339  1
2007 Bond SJ, Farewell VT, Schentag CT, Gladman DD. Predictors for radiological damage in psoriatic arthritis: results from a single centre. Annals of the Rheumatic Diseases. 66: 370-6. PMID 16916855 DOI: 10.1136/ard.2006.056457  1
2007 Ramsey-Goldman R, Gladman D. Disease Development and Outcome Systemic Lupus Erythematosus: a Companion to Rheumatology. 24-31. DOI: 10.1016/B978-0-323-04434-9.50008-7  1
2007 Gladman DD. Clinical features of psoriatic arthritis Psoriatic and Reactive Arthritis: a Companion to Rheumatology. 11-18. DOI: 10.1016/B978-0-323-03622-1.50008-2  1
2006 Gladman DD. Clinical, radiological, and functional assessment in psoriatic arthritis: Is it different from other inflammatory joint diseases? Annals of the Rheumatic Diseases. 65. PMID 17038466 DOI: 10.1136/ard.2006.058453  1
2006 Gladman DD. A novel, disease-specific quality-of-life instrument for patients with SLE: Commentary Nature Clinical Practice Rheumatology. 2: 132-133. PMID 16932672 DOI: 10.1038/ncprheum0136  1
2006 Gladman DD, Mease PJ. Towards international guidelines for the management of psoriatic arthritis Journal of Rheumatology. 33: 1228-1230. PMID 16821263  1
2006 Butt C, Gladman D, Rahman P. PPAR-γ gene polymorphisms and psoriatic arthritis Journal of Rheumatology. 33: 1631-1633. PMID 16783862  1
2006 Prasad R, Ibañez D, Gladman D, Urowitz M. Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus Lupus. 15: 285-291. PMID 16761503 DOI: 10.1191/0961203306lu2302oa  1
2006 Maksymowych WP, Rahman P, Reeve JP, Gladman DD, Peddle L, Inman RD. Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis and Rheumatism. 54: 974-85. PMID 16508980 DOI: 10.1002/art.21642  1
2006 Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Research & Therapy. 8: R27. PMID 16507123 DOI: 10.1186/ar1880  1
2006 Urowitz MB, Gladman DD, Ibanez D, Berliner Y. Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: A quality improvement study Annals of the Rheumatic Diseases. 65: 115-117. PMID 16344496 DOI: 10.1136/ard.2005.038802  1
2006 Rahman P, Siannis F, Butt C, Farewell V, Peddle L, Pellett F, Gladman D. TNFα polymorphisms and risk of psoriatic arthritis Annals of the Rheumatic Diseases. 65: 919-923. PMID 16284098 DOI: 10.1136/ard.2005.039164  1
2006 Kavanaugh A, Antoni C, Krueger GG, Yan S, Bala M, Dooley LT, Beutler A, Guzzo C, Gladman D. Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 65: 471-7. PMID 16096330 DOI: 10.1136/ard.2005.040196  1
2005 Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States. Journal of the American Academy of Dermatology. 53: 573. PMID 16198775 DOI: 10.1016/j.jaad.2005.03.046  1
2005 Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheumatic Diseases Clinics of North America. 31: 329-54, vii-viii. PMID 15922149 DOI: 10.1016/j.rdc.2005.01.001  1
2005 Urowitz MB, Gladman DD. Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience. Rheumatic Diseases Clinics of North America. 31: 211-21, v. PMID 15922142 DOI: 10.1016/j.rdc.2005.01.008  1
2005 Gladman DD. Traditional and newer therapeutic options for psoriatic arthritis: An evidence-based review Drugs. 65: 1223-1238. PMID 15916449 DOI: 10.2165/00003495-200565090-00004  1
2005 Ibañez D, Gladman DD, Urowitz MB. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. The Journal of Rheumatology. 32: 824-7. PMID 15868616  1
2005 Butt C, Rahman P, Siannis F, Farewell VT, Gladman DD. Corneodesmosin polymorphisms in psoriatic arthritis [1] Rheumatology. 44: 684-685. PMID 15716318 DOI: 10.1093/rheumatology/keh570  1
2005 Gladman DD. Consensus exercise on domains in psoriatic arthritis Annals of the Rheumatic Diseases. 64. PMID 15708924 DOI: 10.1136/ard.2004.030882  1
2005 Gladman DD, Ritchlin C, Helliwell PS. Psoriatic arthritis clinical registries and genomics Annals of the Rheumatic Diseases. 64. PMID 15708920 DOI: 10.1136/ard.2004.030973  1
2005 Gladman DD, Menter A. Introduction/overview on clinical registries Annals of the Rheumatic Diseases. 64. PMID 15708919 DOI: 10.1136/ard.2004.030825  1
2005 Rahman P, Butt C, Siannis F, Farewell VT, Peddle L, Pellett FJ, Schentag C, Gladman DD. Association of SEEK1 and psoriatic arthritis in two distinct Canadian populations Annals of the Rheumatic Diseases. 64: 1370-1372. PMID 15708881 DOI: 10.1136/ard.2004.031765  1
2005 Gladman DD, Farewell VT. Longitudinal cohort studies Journal of Rheumatology. 32: 30-32. PMID 15660462  1
2005 Brockbank JE, Stein M, Schentag CT, Gladman DD. Dactylitis in psoriatic arthritis: a marker for disease severity? Annals of the Rheumatic Diseases. 64: 188-90. PMID 15271771 DOI: 10.1136/ard.2003.018184  1
2005 Gladman DD. Discussion: Clinical features, epidemiology, classification criteria, and quality of life in psoriasis and psoriatic arthritis Annals of the Rheumatic Diseases. 64. DOI: 10.1136/ard.2004.030767  1
2005 Gladman DD. Spondyloarthropathies: Editorial comment Current Opinion in Rheumatology. 17: 393-394. DOI: 10.1097/01.bor.0000167751.55426.db  1
2005 Gladman DD. Psoriatic arthrits Psoriasis and Psoriatic Arthritis: An Integrated Approach. 57-65. DOI: 10.1007/3-540-27190-2_7  1
2005 Rahman P, Gladman DD. Psoriatic arthritis Psoriasis and Psoriatic Arthritis: An Integrated Approach. 12-21. DOI: 10.1007/3-540-27190-2_3  1
2004 Tandon A, Ibañez D, Gladman DD, Urowitz MB. The effect of pregnancy on lupus nephritis. Arthritis and Rheumatism. 50: 3941-6. PMID 15593212 DOI: 10.1002/art.20638  1
2004 Abu-Shakra M, Gladman DD, Urowitz MB. Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmunity Reviews. 3: 418-20. PMID 15351308 DOI: 10.1016/j.autrev.2004.07.003  1
2004 Prasad R, Gladman D. Current and investigational treatment of psoriatic arthritis Expert Opinion On Investigational Drugs. 13: 139-150. PMID 14996648 DOI: 10.1517/13543784.13.2.139  1
2004 Feletar M, Brockbank JE, Schentag CT, Lapp V, Gladman DD. Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Annals of the Rheumatic Diseases. 63: 156-61. PMID 14722204 DOI: 10.1136/ard.2003.006775  1
2004 Gladman DD. Epidemiology of systemic lupus erythematosus Systemic Lupus Erythematosus: Fourth Edition. 697-715. DOI: 10.1016/B978-012433901-9/50026-0  1
2003 Bruce IN, Urowitz MB, Gladman DD, Ibañez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis and Rheumatism. 48: 3159-67. PMID 14613278 DOI: 10.1002/art.11296  0.44
2003 Ibañez D, Urowitz MB, Gladman DD. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. The Journal of Rheumatology. 30: 1977-82. PMID 12966601  1
2003 Gladman DD, Hirani N, Ibañez D, Urowitz MB. Clinically active serologically quiescent systemic lupus erythematosus. The Journal of Rheumatology. 30: 1960-2. PMID 12966598  1
2003 Gladman DD, Farewell VT, Pellett F, Schentag C, Rahman P. HLA is a candidate region for psoriatic arthritis: Evidence for excessive HLA sharing in sibling pairs Human Immunology. 64: 887-889. PMID 12941544 DOI: 10.1016/S0198-8859(03)00162-9  1
2003 Gladman DD. Established criteria for disease controlling drugs in ankylosing spondylitis Annals of the Rheumatic Diseases. 62: 793-794. PMID 12922946 DOI: 10.1136/ard.62.9.793  1
2003 Gladman DD. Effectiveness of psoriatic arthritis therapies Seminars in Arthritis and Rheumatism. 33: 29-37. PMID 12920694 DOI: 10.1053/sarh.2002.50024  1
2003 Feletar M, Ibañez D, Urowitz MB, Gladman DD. The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Arthritis and Rheumatism. 48: 2067-9. PMID 12847702 DOI: 10.1002/art.11167  1
2003 Khan M, Schentag C, Gladman DD. Clinical and radiological changes during psoriatic arthritis disease progression Journal of Rheumatology. 30: 1022-1026. PMID 12734899  1
Show low-probability matches.